Drug,DrugMechOfAction,DrugTargetAll,DrugRegulonAll,DrugProgramAll,DrugConstrainedRegulonActivity,DrugRegulonOverActive,DrugRegulonUnderActive,DrugConstrainedProgramActivity,DrugProgramOverActive,DrugProgramUnderActive,DrugMeanRMSTRegulon,MutationSymbol,IfCancerDriverMutation,RegulatorSymbol,RegulatorType,MutationRegulatorEdge,MutationRegulonEdge,SpearmanCorrelationTFAndEigenGene,IfCRISPR-Cas9SignificantTF,Cancer_PhaseIV,Miner_Target_Type,IfDETFForTCGAGBM,RNAiTFGeneEssentialityAchilles,DrugTrialPhaseGBM,patient,MutatedInPatient,TargetMutatedInPatient,Program Activity Summary,Regulon Activity Summary,Max GBM Trial Phase.DrugTrialPhaseGBM,Other FDA Appr.
ROCURONIUM,Muscle-type nicotinic acetylcholine receptor antagonist,CHRNB1,"439,1638,2031,2106",91,1,"439,1638,2031,2106",NA,NA,NA,NA,214.2897268909091,ATRX,yes,LEF1,TF,-1,-5.283671066,0.490108127,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 4 U: 0 A: 4,None,TRUE
ROCURONIUM,Muscle-type nicotinic acetylcholine receptor antagonist,CHRNB1,"439,1638,2031,2106",91,1,"439,1638,2031,2106",NA,NA,NA,NA,214.2897268909091,ATRX,yes,RORA,TF,-1,-5.726907249,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 4 U: 0 A: 4,None,TRUE
ROCURONIUM,Muscle-type nicotinic acetylcholine receptor antagonist,CHRNB1,"439,1638,2031,2106",91,1,"439,1638,2031,2106",NA,NA,NA,NA,214.2897268909091,ATRX,yes,FOXC1,TF,-1,-6.124032141,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 4 U: 0 A: 4,None,TRUE
ROCURONIUM,Muscle-type nicotinic acetylcholine receptor antagonist,CHRNB1,"439,1638,2031,2106",91,1,"439,1638,2031,2106",NA,NA,NA,NA,214.2897268909091,ATRX,yes,hsa-mir-504,miRNA,1,-5.765024776,-0.424987379,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 4 U: 0 A: 4,None,TRUE
ROCURONIUM,Muscle-type nicotinic acetylcholine receptor antagonist,CHRNB1,"439,1638,2031,2106",91,1,"439,1638,2031,2106",NA,NA,NA,NA,214.2897268909091,IDH1,yes,LEF1,TF,-1,-7.304272808,0.490108127,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 4 U: 0 A: 4,None,TRUE
ROCURONIUM,Muscle-type nicotinic acetylcholine receptor antagonist,CHRNB1,"439,1638,2031,2106",91,1,"439,1638,2031,2106",NA,NA,NA,NA,214.2897268909091,IDH1,yes,RORA,TF,-1,-8.153350511,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 4 U: 0 A: 4,None,TRUE
ROCURONIUM,Muscle-type nicotinic acetylcholine receptor antagonist,CHRNB1,"439,1638,2031,2106",91,1,"439,1638,2031,2106",NA,NA,NA,NA,214.2897268909091,IDH1,yes,FOXC1,TF,-1,-7.881164458,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 4 U: 0 A: 4,None,TRUE
ROCURONIUM,Muscle-type nicotinic acetylcholine receptor antagonist,CHRNB1,"439,1638,2031,2106",91,1,"439,1638,2031,2106",NA,NA,NA,NA,214.2897268909091,SEMA3C,NA,RORA,TF,-1,-3.697758686,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 4 U: 0 A: 4,None,TRUE
ROCURONIUM,Muscle-type nicotinic acetylcholine receptor antagonist,CHRNB1,"439,1638,2031,2106",91,1,"439,1638,2031,2106",NA,NA,NA,NA,214.2897268909091,TP53,yes,MAFB,TF,-1,-6.010206319,0.446212619,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 4 U: 0 A: 4,None,TRUE
ROCURONIUM,Muscle-type nicotinic acetylcholine receptor antagonist,CHRNB1,"439,1638,2031,2106",91,1,"439,1638,2031,2106",NA,NA,NA,NA,214.2897268909091,TP53,yes,RORA,TF,-1,-6.248205922,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 4 U: 0 A: 4,None,TRUE
ROCURONIUM,Muscle-type nicotinic acetylcholine receptor antagonist,CHRNB1,"439,1638,2031,2106",91,1,"439,1638,2031,2106",NA,NA,NA,NA,214.2897268909091,TP53,yes,FOXC1,TF,-1,-6.191878823,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 4 U: 0 A: 4,None,TRUE
DIAZOXIDE,"Potassium channel, inwardly rectifying, subfamily J, member 8 opener",KCNJ8,"238,796",12,1,"238,796",NA,1,12,NA,281.7798611125,ATRX,yes,JUN,TF,-1,-5.378276635,0.600594784,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 2 U: 0 A: 2,None,TRUE
DIAZOXIDE,"Potassium channel, inwardly rectifying, subfamily J, member 8 opener",KCNJ8,"238,796",12,1,"238,796",NA,1,12,NA,281.7798611125,DNAH5,NA,JUN,TF,1,2.536945782,0.600594784,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 2 U: 0 A: 2,None,TRUE
DIAZOXIDE,"Potassium channel, inwardly rectifying, subfamily J, member 8 opener",KCNJ8,"238,796",12,1,"238,796",NA,1,12,NA,281.7798611125,GPR98,NA,JUN,TF,-1,-3.026238353,0.600594784,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 2 U: 0 A: 2,None,TRUE
DIAZOXIDE,"Potassium channel, inwardly rectifying, subfamily J, member 8 opener",KCNJ8,"238,796",12,1,"238,796",NA,1,12,NA,281.7798611125,IDH1,yes,JUN,TF,-1,-5.739212114,0.600594784,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 2 U: 0 A: 2,None,TRUE
DIAZOXIDE,"Potassium channel, inwardly rectifying, subfamily J, member 8 opener",KCNJ8,"238,796",12,1,"238,796",NA,1,12,NA,281.7798611125,NF1,yes,JUN,TF,1,2.268650509,0.600594784,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 2 U: 0 A: 2,None,TRUE
DIAZOXIDE,"Potassium channel, inwardly rectifying, subfamily J, member 8 opener",KCNJ8,"238,796",12,1,"238,796",NA,1,12,NA,281.7798611125,SEMA3C,NA,JUN,TF,-1,-3.773105967,0.600594784,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 2 U: 0 A: 2,None,TRUE
DIAZOXIDE,"Potassium channel, inwardly rectifying, subfamily J, member 8 opener",KCNJ8,"238,796",12,1,"238,796",NA,1,12,NA,281.7798611125,TP53,yes,STAT5A,TF,-1,-5.255752956,0.602668009,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 1,O: 2 U: 0 A: 2,None,TRUE
DIAZOXIDE,"Potassium channel, inwardly rectifying, subfamily J, member 8 opener",KCNJ8,"238,796",12,1,"238,796",NA,1,12,NA,281.7798611125,TP53,yes,JUN,TF,-1,-4.449354478,0.600594784,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 1,O: 2 U: 0 A: 2,None,TRUE
DEXAMETHASONE,Glucocorticoid receptor agonist,NR3C1,837,91,1,837,NA,NA,NA,NA,239.1776481,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulatorGene,#N/A,-0.092597974,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 1,Phase 2,TRUE
PREDNISONE,Glucocorticoid receptor agonist,NR3C1,837,91,1,837,NA,NA,NA,NA,239.1776481,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulatorGene,#N/A,-0.092597974,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 1,Phase 2,TRUE
TRIAMCINOLONE,Glucocorticoid receptor agonist,NR3C1,837,91,1,837,NA,NA,NA,NA,239.1776481,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulatorGene,#N/A,-0.092597974,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 1,Phase 2,TRUE
BUDESONIDE,Glucocorticoid receptor agonist,NR3C1,837,91,1,837,NA,NA,NA,NA,239.1776481,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulatorGene,#N/A,-0.092597974,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 1,None,TRUE
HYDROCORTISONE,Glucocorticoid receptor agonist,NR3C1,837,91,1,837,NA,NA,NA,NA,239.1776481,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulatorGene,#N/A,-0.092597974,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 1,None,TRUE
MIFEPRISTONE,Glucocorticoid receptor antagonist,NR3C1,837,91,1,837,NA,NA,NA,NA,239.1776481,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulatorGene,#N/A,-0.092597974,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 1,None,TRUE
PREDNISOLONE,Glucocorticoid receptor agonist,NR3C1,837,91,1,837,NA,NA,NA,NA,239.1776481,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulatorGene,#N/A,-0.092597974,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 1,None,TRUE
CARBETOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,ATRX,yes,FOXC1,TF,-1,-6.124032141,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
OXYTOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,ATRX,yes,FOXC1,TF,-1,-6.124032141,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
CARBETOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,IDH1,yes,NFKB1,TF,-1,-7.644356643,0.438395898,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
OXYTOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,IDH1,yes,NFKB1,TF,-1,-7.644356643,0.438395898,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
CARBETOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,IDH1,yes,FOXC1,TF,-1,-7.881164458,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
OXYTOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,IDH1,yes,FOXC1,TF,-1,-7.881164458,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
CARBETOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,LRP2,NA,hsa-mir-338,miRNA,-1,2.178853063,-0.437853739,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
OXYTOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,LRP2,NA,hsa-mir-338,miRNA,-1,2.178853063,-0.437853739,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
CARBETOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.092597974,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
OXYTOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.092597974,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
CARBETOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,TP53,yes,MAFB,TF,-1,-6.010206319,0.446212619,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
OXYTOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,TP53,yes,MAFB,TF,-1,-6.010206319,0.446212619,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
CARBETOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,TP53,yes,FOXC1,TF,-1,-6.191878823,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
OXYTOCIN,Oxytocin receptor agonist,OXTR,"405,439,837,1939,2031","48,91",1,"405,439,837,1939,2031",NA,NA,NA,NA,236.43391287142856,TP53,yes,FOXC1,TF,-1,-6.191878823,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
NIRAPARIB,Poly [ADP-ribose] polymerase 2 inhibitor,PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,ATRX,yes,ZNF281,TF,1,2.791241786,0.696549726,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,TRUE
NIRAPARIB,Poly [ADP-ribose] polymerase 2 inhibitor,PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,ATRX,yes,SOX5,TF,1,2.243461218,0.716152893,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,TRUE
OLAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,ATRX,yes,ZNF281,TF,1,2.791241786,0.696549726,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 3,TRUE
OLAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,ATRX,yes,SOX5,TF,1,2.243461218,0.716152893,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 3,TRUE
RUCAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,ATRX,yes,ZNF281,TF,1,2.791241786,0.696549726,#N/A,#N/A,RegulonGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 1,FALSE
RUCAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,ATRX,yes,SOX5,TF,1,2.243461218,0.716152893,yes,#N/A,RegulonGene,#N/A,0.017516857,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 1,FALSE
VELIPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,ATRX,yes,ZNF281,TF,1,2.791241786,0.696549726,#N/A,#N/A,RegulonGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,FALSE
VELIPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,ATRX,yes,SOX5,TF,1,2.243461218,0.716152893,yes,#N/A,RegulonGene,#N/A,0.017516857,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,FALSE
NIRAPARIB,Poly [ADP-ribose] polymerase 2 inhibitor,PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,ZNF281,TF,1,5.821698494,0.696549726,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,TRUE
NIRAPARIB,Poly [ADP-ribose] polymerase 2 inhibitor,PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,SOX5,TF,1,4.597262215,0.716152893,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,TRUE
NIRAPARIB,Poly [ADP-ribose] polymerase 2 inhibitor,PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,POU2F1,TF,1,5.435696178,0.658692831,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.052469964,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,TRUE
OLAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,ZNF281,TF,1,5.821698494,0.696549726,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 3,TRUE
OLAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,SOX5,TF,1,4.597262215,0.716152893,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 3,TRUE
OLAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,POU2F1,TF,1,5.435696178,0.658692831,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.052469964,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 3,TRUE
RUCAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,ZNF281,TF,1,5.821698494,0.696549726,#N/A,#N/A,RegulonGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 1,FALSE
RUCAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,SOX5,TF,1,4.597262215,0.716152893,yes,#N/A,RegulonGene,#N/A,0.017516857,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 1,FALSE
RUCAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,POU2F1,TF,1,5.435696178,0.658692831,yes,#N/A,RegulonGene,#N/A,0.052469964,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 1,FALSE
VELIPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,ZNF281,TF,1,5.821698494,0.696549726,#N/A,#N/A,RegulonGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,FALSE
VELIPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,SOX5,TF,1,4.597262215,0.716152893,yes,#N/A,RegulonGene,#N/A,0.017516857,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,FALSE
VELIPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,IDH1,yes,POU2F1,TF,1,5.435696178,0.658692831,yes,#N/A,RegulonGene,#N/A,0.052469964,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,FALSE
NIRAPARIB,Poly [ADP-ribose] polymerase 2 inhibitor,PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,ZNF281,TF,1,2.870012115,0.696549726,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,TRUE
NIRAPARIB,Poly [ADP-ribose] polymerase 2 inhibitor,PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,SOX5,TF,1,3.216375962,0.716152893,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,TRUE
NIRAPARIB,Poly [ADP-ribose] polymerase 2 inhibitor,PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,POU2F1,TF,1,3.182943928,0.658692831,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.052469964,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,TRUE
OLAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,ZNF281,TF,1,2.870012115,0.696549726,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 3,TRUE
OLAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,SOX5,TF,1,3.216375962,0.716152893,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 3,TRUE
OLAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,POU2F1,TF,1,3.182943928,0.658692831,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.052469964,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 3,TRUE
RUCAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,ZNF281,TF,1,2.870012115,0.696549726,#N/A,#N/A,RegulonGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 1,FALSE
RUCAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,SOX5,TF,1,3.216375962,0.716152893,yes,#N/A,RegulonGene,#N/A,0.017516857,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 1,FALSE
RUCAPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,POU2F1,TF,1,3.182943928,0.658692831,yes,#N/A,RegulonGene,#N/A,0.052469964,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 1,FALSE
VELIPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,ZNF281,TF,1,2.870012115,0.696549726,#N/A,#N/A,RegulonGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,FALSE
VELIPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,SOX5,TF,1,3.216375962,0.716152893,yes,#N/A,RegulonGene,#N/A,0.017516857,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,FALSE
VELIPARIB,"PARP 1, 2 and 3 inhibitor",PARP2,"337,1170,1675",72,1,"337,1170,1675",NA,NA,NA,NA,-302.9332541375,TP53,yes,POU2F1,TF,1,3.182943928,0.658692831,yes,#N/A,RegulonGene,#N/A,0.052469964,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 3 U: 0 A: 3,Phase 2,FALSE
SORAFENIB,Serine/threonine-protein kinase RAF inhibitor,RAF1,1889,64,1,1889,NA,NA,NA,NA,-247.5424837,TP53,yes,MYBL1,TF,1,3.307806404,0.631273234,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.053208317,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 1,Phase 2,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,ATRX,yes,IRF1,TF,-1,-3.881899995,0.312690555,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,ATRX,yes,TCF3,TF,-1,-3.82507909,0.524746076,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.161212872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,ATRX,yes,SMAD1,TF,-1,-3.017583829,0.695409121,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,ATRX,yes,IRF1,TF,-1,-3.881899995,0.312690555,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,ATRX,yes,TCF3,TF,-1,-3.82507909,0.524746076,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.161212872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,ATRX,yes,SMAD1,TF,-1,-3.017583829,0.695409121,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,DNAH5,NA,SMAD1,TF,1,2.160883898,0.695409121,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,DNAH5,NA,SMAD1,TF,1,2.160883898,0.695409121,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,GPR98,NA,SMAD1,TF,-1,-3.034975972,0.695409121,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,GPR98,NA,HIF1A,TF,-1,-2.39942614,0.623091248,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.05107959,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,GPR98,NA,SMAD1,TF,-1,-3.034975972,0.695409121,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,GPR98,NA,HIF1A,TF,-1,-2.39942614,0.623091248,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.05107959,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,IDH1,yes,IRF1,TF,-1,-7.585212207,0.312690555,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,IDH1,yes,TCF3,TF,-1,-7.189779608,0.524746076,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.161212872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,IDH1,yes,SMAD1,TF,-1,-6.419579675,0.695409121,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,IDH1,yes,HIF1A,TF,-1,-5.339901843,0.623091248,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.05107959,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,IDH1,yes,IRF1,TF,-1,-7.585212207,0.312690555,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,IDH1,yes,TCF3,TF,-1,-7.189779608,0.524746076,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.161212872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,IDH1,yes,SMAD1,TF,-1,-6.419579675,0.695409121,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,IDH1,yes,HIF1A,TF,-1,-5.339901843,0.623091248,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.05107959,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,LRP2,NA,HIF1A,TF,1,2.738755406,0.623091248,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.05107959,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,LRP2,NA,HIF1A,TF,1,2.738755406,0.623091248,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.05107959,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,SEMA3C,NA,MAFG,TF,-1,-2.9275437,0.35362985,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.060839113,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,SEMA3C,NA,HIF1A,TF,-1,-2.356501045,0.623091248,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.05107959,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,SEMA3C,NA,MAFG,TF,-1,-2.9275437,0.35362985,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.060839113,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,SEMA3C,NA,HIF1A,TF,-1,-2.356501045,0.623091248,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.05107959,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,TP53,yes,IRF1,TF,-1,-3.480691856,0.312690555,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,TP53,yes,SMAD1,TF,-1,-2.973257281,0.695409121,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
BEVACIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,TP53,yes,HIF1A,TF,-1,-3.660316008,0.623091248,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.05107959,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,Phase 2,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,TP53,yes,IRF1,TF,-1,-3.480691856,0.312690555,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,TP53,yes,SMAD1,TF,-1,-2.973257281,0.695409121,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
RANIBIZUMAB,Vascular endothelial growth factor A inhibitor,VEGFA,"42,646,1709,1774,2946","44,169",1,"42,646,1709,1774,2946",NA,NA,NA,NA,280.64568534375,TP53,yes,HIF1A,TF,-1,-3.660316008,0.623091248,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.05107959,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 5 U: 0 A: 5,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,TCF3,TF,-1,-4.236788298,0.30191969,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.161212872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,TCF3,TF,-1,-4.236788298,0.30191969,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.161212872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,FOXC1,TF,-1,-4.572767571,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,FOXC1,TF,-1,-4.572767571,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,NR2E1,TF,-1,-4.180631771,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,NR2E1,TF,-1,-4.180631771,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,CEBPB,TF,-1,-4.774752905,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,CEBPB,TF,-1,-4.774752905,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,RORA,TF,-1,-5.726907249,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,RORA,TF,-1,-5.726907249,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,FOXC1,TF,-1,-6.124032141,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,FOXC1,TF,-1,-6.124032141,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,hsa-mir-504,miRNA,1,-5.765024776,-0.424987379,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,hsa-mir-504,miRNA,1,-5.765024776,-0.424987379,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,TCF3,TF,-1,-4.236788298,0.30191969,#N/A,#N/A,RegulonGene,yes,0.161212872,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,FOXC1,TF,-1,-4.572767571,0.437464091,#N/A,#N/A,RegulonGene,#N/A,-0.112566588,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,NR2E1,TF,-1,-4.180631771,0.597949929,#N/A,#N/A,RegulonGene,#N/A,-0.00778872,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,CEBPB,TF,-1,-4.774752905,0.403617678,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,RORA,TF,-1,-5.726907249,0.368665976,#N/A,#N/A,RegulonGene,#N/A,-0.02197661,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,FOXC1,TF,-1,-6.124032141,0.337342603,#N/A,#N/A,RegulonGene,#N/A,-0.112566588,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,ATRX,yes,hsa-mir-504,miRNA,1,-5.765024776,-0.424987379,#N/A,#N/A,RegulonGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,GPR98,NA,BACH1,TF,-1,-2.606856849,0.378324426,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.087227094,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,GPR98,NA,BACH1,TF,-1,-2.606856849,0.378324426,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.087227094,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,GPR98,NA,BACH1,TF,-1,-2.606856849,0.378324426,#N/A,#N/A,RegulonGene,#N/A,-0.087227094,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,TCF3,TF,-1,-11.23353208,0.30191969,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.161212872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,TCF3,TF,-1,-11.23353208,0.30191969,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.161212872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,FOXC1,TF,-1,-12.05038404,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,FOXC1,TF,-1,-12.05038404,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,NR2E1,TF,-1,-10.10789611,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,NR2E1,TF,-1,-10.10789611,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,CEBPB,TF,-1,-11.41373101,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,CEBPB,TF,-1,-11.41373101,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,RORA,TF,-1,-8.153350511,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,RORA,TF,-1,-8.153350511,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,FOXC1,TF,-1,-7.881164458,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,FOXC1,TF,-1,-7.881164458,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,TCF3,TF,-1,-11.23353208,0.30191969,#N/A,#N/A,RegulonGene,yes,0.161212872,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,FOXC1,TF,-1,-12.05038404,0.437464091,#N/A,#N/A,RegulonGene,#N/A,-0.112566588,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,NR2E1,TF,-1,-10.10789611,0.597949929,#N/A,#N/A,RegulonGene,#N/A,-0.00778872,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,CEBPB,TF,-1,-11.41373101,0.403617678,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,RORA,TF,-1,-8.153350511,0.368665976,#N/A,#N/A,RegulonGene,#N/A,-0.02197661,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,IDH1,yes,FOXC1,TF,-1,-7.881164458,0.337342603,#N/A,#N/A,RegulonGene,#N/A,-0.112566588,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.245899418,-0.387152949,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.245899418,-0.387152949,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.618172409,-0.395228413,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.618172409,-0.395228413,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.320989975,-0.380435107,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.320989975,-0.380435107,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.728349707,-0.368996416,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.728349707,-0.368996416,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.413381654,-0.383890337,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.413381654,-0.383890337,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.492321138,-0.392314546,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.492321138,-0.392314546,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,3.095385462,-0.386732147,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,3.095385462,-0.386732147,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.999172667,-0.37816203,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.999172667,-0.37816203,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.928325505,-0.355717712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.928325505,-0.355717712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.178853063,-0.437853739,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.178853063,-0.437853739,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.245899418,-0.387152949,#N/A,#N/A,RegulonGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.618172409,-0.395228413,#N/A,#N/A,RegulonGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.320989975,-0.380435107,#N/A,#N/A,RegulonGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.728349707,-0.368996416,#N/A,#N/A,RegulonGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.413381654,-0.383890337,#N/A,#N/A,RegulonGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.492321138,-0.392314546,#N/A,#N/A,RegulonGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,3.095385462,-0.386732147,#N/A,#N/A,RegulonGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.999172667,-0.37816203,#N/A,#N/A,RegulonGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.928325505,-0.355717712,#N/A,#N/A,RegulonGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,LRP2,NA,hsa-mir-338,miRNA,-1,2.178853063,-0.437853739,#N/A,#N/A,RegulonGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,FOXC1,TF,1,2.732738556,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,FOXC1,TF,1,2.732738556,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,MTF1,TF,1,2.585082296,0.325833084,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.032928344,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,MTF1,TF,1,2.585082296,0.325833084,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.032928344,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,BACH1,TF,1,2.24461646,0.378324426,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.087227094,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,BACH1,TF,1,2.24461646,0.378324426,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.087227094,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,MEF2A,TF,1,2.649342632,0.385471054,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,MEF2A,TF,1,2.649342632,0.385471054,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,CEBPB,TF,1,3.226007015,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,CEBPB,TF,1,3.226007015,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,FOXC1,TF,1,2.732738556,0.437464091,#N/A,#N/A,RegulonGene,#N/A,-0.112566588,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,MTF1,TF,1,2.585082296,0.325833084,yes,#N/A,RegulonGene,#N/A,0.032928344,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,BACH1,TF,1,2.24461646,0.378324426,#N/A,#N/A,RegulonGene,#N/A,-0.087227094,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,MEF2A,TF,1,2.649342632,0.385471054,#N/A,#N/A,RegulonGene,yes,0.04207445,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,NF1,yes,CEBPB,TF,1,3.226007015,0.403617678,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,SEMA3C,NA,NR2E1,TF,-1,-2.257683643,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,SEMA3C,NA,NR2E1,TF,-1,-2.257683643,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.092597974,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.092597974,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,SEMA3C,NA,RORA,TF,-1,-3.697758686,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,SEMA3C,NA,RORA,TF,-1,-3.697758686,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,SEMA3C,NA,NR2E1,TF,-1,-2.257683643,0.597949929,#N/A,#N/A,RegulonGene,#N/A,-0.00778872,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,#N/A,RegulonGene,#N/A,-0.092597974,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,SEMA3C,NA,RORA,TF,-1,-3.697758686,0.368665976,#N/A,#N/A,RegulonGene,#N/A,-0.02197661,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,FOXC1,TF,-1,-4.854175065,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,FOXC1,TF,-1,-4.854175065,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,NR2E1,TF,-1,-5.14556202,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,NR2E1,TF,-1,-5.14556202,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,CEBPB,TF,-1,-4.989226568,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,CEBPB,TF,-1,-4.989226568,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,RORA,TF,-1,-6.248205922,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,RORA,TF,-1,-6.248205922,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
DEXCHLORPHENIRAMINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,FOXC1,TF,-1,-6.191878823,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
HISTAMINE,Histamine H1 receptor agonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,FOXC1,TF,-1,-6.191878823,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,None,TRUE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,FOXC1,TF,-1,-4.854175065,0.437464091,#N/A,#N/A,RegulonGene,#N/A,-0.112566588,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,NR2E1,TF,-1,-5.14556202,0.597949929,#N/A,#N/A,RegulonGene,#N/A,-0.00778872,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,CEBPB,TF,-1,-4.989226568,0.403617678,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,RORA,TF,-1,-6.248205922,0.368665976,#N/A,#N/A,RegulonGene,#N/A,-0.02197661,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
CYPROHEPTADINE,Histamine H1 receptor antagonist,HRH1,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3115,3153","42,48,91",0.9459459459459459,"462,482,642,678,837,838,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,NA,NA,NA,290.91602764324324,TP53,yes,FOXC1,TF,-1,-6.191878823,0.337342603,#N/A,#N/A,RegulonGene,#N/A,-0.112566588,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 15 U: 0 A: 16,Early Phase 1,FALSE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,ATRX,yes,IRF1,TF,-1,-3.881340746,0.527614184,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,ATRX,yes,IRF1,TF,-1,-3.881340746,0.527614184,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,ATRX,yes,IRF1,TF,-1,-3.881340746,0.527614184,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,ATRX,yes,MAX,TF,-1,-4.025498363,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,ATRX,yes,MAX,TF,-1,-4.025498363,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,ATRX,yes,MAX,TF,-1,-4.025498363,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,DNAH5,NA,BCL6,TF,1,2.159430899,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,DNAH5,NA,BCL6,TF,1,2.159430899,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,DNAH5,NA,BCL6,TF,1,2.159430899,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,GPR98,NA,MTF1,TF,-1,-5.120396613,0.375173629,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.032928344,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,GPR98,NA,MTF1,TF,-1,-5.120396613,0.375173629,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.032928344,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,GPR98,NA,MTF1,TF,-1,-5.120396613,0.375173629,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.032928344,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,GPR98,NA,BCL6,TF,-1,-4.851964641,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,GPR98,NA,BCL6,TF,-1,-4.851964641,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,GPR98,NA,BCL6,TF,-1,-4.851964641,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,GPR98,NA,ATF5,TF,-1,-5.761883443,0.378111064,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,GPR98,NA,ATF5,TF,-1,-5.761883443,0.378111064,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,GPR98,NA,ATF5,TF,-1,-5.761883443,0.378111064,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,IDH1,yes,IRF1,TF,-1,-8.503373505,0.527614184,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,IDH1,yes,IRF1,TF,-1,-8.503373505,0.527614184,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,IDH1,yes,IRF1,TF,-1,-8.503373505,0.527614184,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,IDH1,yes,MAX,TF,-1,-7.663318703,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,IDH1,yes,MAX,TF,-1,-7.663318703,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,IDH1,yes,MAX,TF,-1,-7.663318703,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,NF1,yes,MAX,TF,1,4.095038391,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,NF1,yes,MAX,TF,1,4.095038391,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,NF1,yes,MAX,TF,1,4.095038391,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,NF1,yes,MTF1,TF,1,4.375581069,0.375173629,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.032928344,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,NF1,yes,MTF1,TF,1,4.375581069,0.375173629,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.032928344,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,NF1,yes,MTF1,TF,1,4.375581069,0.375173629,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.032928344,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,NF1,yes,ATF5,TF,1,4.370023425,0.378111064,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,NF1,yes,ATF5,TF,1,4.370023425,0.378111064,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,NF1,yes,ATF5,TF,1,4.370023425,0.378111064,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,PIK3CA,yes,MAX,TF,1,2.187067289,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,PIK3CA,yes,MAX,TF,1,2.187067289,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,PIK3CA,yes,MAX,TF,1,2.187067289,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,PIK3CA,yes,BCL6,TF,1,2.146642273,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,PIK3CA,yes,BCL6,TF,1,2.146642273,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,PIK3CA,yes,BCL6,TF,1,2.146642273,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,SEMA3C,NA,BCL6,TF,-1,-3.273883394,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,SEMA3C,NA,BCL6,TF,-1,-3.273883394,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,SEMA3C,NA,BCL6,TF,-1,-3.273883394,0.341602951,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.15023748,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,TP53,yes,IRF1,TF,-1,-3.156527058,0.527614184,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,TP53,yes,IRF1,TF,-1,-3.156527058,0.527614184,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,TP53,yes,IRF1,TF,-1,-3.156527058,0.527614184,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,TP53,yes,MAX,TF,-1,-3.59464472,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,TP53,yes,MAX,TF,-1,-3.59464472,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,TP53,yes,MAX,TF,-1,-3.59464472,0.326974202,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177842791,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
ARZOXIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,ZNF99,NA,ATF5,TF,-1,-11.25774844,0.378111064,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
FULVESTRANT,Estrogen receptor antagonist,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,ZNF99,NA,ATF5,TF,-1,-11.25774844,0.378111064,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
TOREMIFENE,Estrogen receptor modulator,ESR2,"37,538,677,1307,1523",3,0.8235294117647058,"37,677,1307,1523",NA,1,3,NA,466.06700324705884,ZNF99,NA,ATF5,TF,-1,-11.25774844,0.378111064,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 4 U: 0 A: 5,None,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,IDH1,yes,SATB1,TF,1,3.182757101,0.328599874,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,IDH1,yes,PBX1,TF,1,2.724365523,0.523151853,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.007961587,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,IDH1,yes,BPTF,TF,1,3.210544209,0.684460067,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.197820689,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,IDH1,yes,FOXJ2,TF,1,4.00627145,0.435941288,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.114160794,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,TP53,yes,SATB1,TF,1,4.032071338,0.328599874,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,TP53,yes,PBX1,TF,1,4.50775356,0.523151853,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.007961587,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,TP53,yes,BPTF,TF,1,4.242730294,0.684460067,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.197820689,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,ATRX,yes,LEF1,TF,-1,-3.505281954,0.586474346,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,GPR98,NA,NFKB1,TF,-1,-2.361661402,0.501166697,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,GPR98,NA,LEF1,TF,-1,-2.284221206,0.586474346,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,IDH1,yes,NFKB1,TF,-1,-4.608054224,0.501166697,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,IDH1,yes,LEF1,TF,-1,-6.871561444,0.586474346,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,NF1,yes,LEF1,TF,1,3.393720811,0.586474346,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,PTEN,yes,hsa-mir-328,miRNA,-1,2.163270602,-0.433055206,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,PTEN,yes,hsa-mir-328,miRNA,-1,2.132688349,-0.363223605,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,PTEN,yes,hsa-mir-328,miRNA,-1,2.207449734,-0.430889301,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,ATRX,yes,IRF1,TF,-1,-6.262646474,0.401128348,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,CNTNAP2,NA,IRF2,TF,-1,-2.362003902,0.585350531,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,IDH1,yes,IRF1,TF,-1,-6.881739747,0.401128348,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,SEMA3C,NA,IRF2,TF,-1,-3.317326072,0.585350531,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,TP53,yes,IRF2,TF,-1,-5.088668189,0.585350531,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
METFORMIN,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,"GPD2,NDUFA4L2,NDUFC1","47,410,714,1224,1558,1576,1640,2588,2695,3206","78,81,104,159",0.782608695652174,"47,714,1558,1640,2588,2695,3206",NA,NA,NA,NA,44.35852997826087,TP53,yes,IRF1,TF,-1,-4.9358644,0.401128348,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 4,O: 7 U: 0 A: 10,Phase 2,TRUE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,ATRX,yes,SMAD1,TF,-1,-4.000202535,0.453661663,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,DNAH5,NA,SMAD1,TF,1,2.192883842,0.453661663,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,DNAH5,NA,BCL6,TF,1,2.159430899,0.341602951,yes,#N/A,RegulonGene,yes,-0.15023748,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,GPR98,NA,SMAD1,TF,-1,-4.547191532,0.453661663,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,GPR98,NA,MEF2A,TF,-1,-4.151455272,0.643249466,#N/A,#N/A,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,GPR98,NA,BCL6,TF,-1,-4.851964641,0.341602951,yes,#N/A,RegulonGene,yes,-0.15023748,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,GPR98,NA,MAFB,TF,-1,-4.869968563,0.517683823,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,IDH1,yes,SMAD1,TF,-1,-8.764227556,0.453661663,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,NF1,yes,MEF2A,TF,1,4.342771626,0.643249466,#N/A,#N/A,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,NF1,yes,MAFB,TF,1,4.363931234,0.517683823,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,PIK3CA,yes,BCL6,TF,1,2.146642273,0.341602951,yes,#N/A,RegulonGene,yes,-0.15023748,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,SEMA3C,NA,SMAD1,TF,-1,-3.277387235,0.453661663,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,SEMA3C,NA,BCL6,TF,-1,-3.273883394,0.341602951,yes,#N/A,RegulonGene,yes,-0.15023748,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,TP53,yes,SMAD1,TF,-1,-3.545167951,0.453661663,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,TP53,yes,MAFB,TF,-1,-3.468401646,0.517683823,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,ATRX,yes,hsa-mir-551b,miRNA,1,-3.294185758,-0.344726091,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,ATRX,yes,hsa-mir-551b,miRNA,1,-3.418568268,-0.392135484,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,GPR98,NA,TEAD4,TF,-1,-4.658428385,0.320363837,yes,#N/A,RegulonGene,yes,-0.032367307,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,GPR98,NA,BACH1,TF,-1,-4.485143062,0.594262478,#N/A,#N/A,RegulonGene,#N/A,-0.087227094,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,NF1,yes,TEAD4,TF,1,2.922315641,0.320363837,yes,#N/A,RegulonGene,yes,-0.032367307,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
CILENGITIDE,Integrin alpha-V/beta-3 antagonist,"ITGB3,ITGB5","438,481,1302,1523,1706,3118,3232","3,27",0.7142857142857143,"438,481,1523,1706",NA,1,"3,27",NA,389.79189055238095,NF1,yes,BACH1,TF,1,2.85111677,0.594262478,#N/A,#N/A,RegulonGene,#N/A,-0.087227094,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 2,O: 4 U: 0 A: 7,Phase 2,FALSE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,ATRX,yes,TCF3,TF,-1,-4.236788298,0.30191969,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.161212872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,ATRX,yes,FOXC1,TF,-1,-4.572767571,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,ATRX,yes,NR2E1,TF,-1,-4.180631771,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,ATRX,yes,CEBPB,TF,-1,-4.774752905,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,ATRX,yes,RORA,TF,-1,-5.726907249,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,ATRX,yes,FOXC1,TF,-1,-6.124032141,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,ATRX,yes,hsa-mir-504,miRNA,1,-5.765024776,-0.424987379,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,GPR98,NA,BACH1,TF,-1,-2.606856849,0.378324426,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.087227094,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,IDH1,yes,TCF3,TF,-1,-11.23353208,0.30191969,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.161212872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,IDH1,yes,FOXC1,TF,-1,-12.05038404,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,IDH1,yes,NR2E1,TF,-1,-10.10789611,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,IDH1,yes,CEBPB,TF,-1,-11.41373101,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,IDH1,yes,RORA,TF,-1,-8.153350511,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,IDH1,yes,FOXC1,TF,-1,-7.881164458,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,LRP2,NA,hsa-mir-338,miRNA,-1,2.245899418,-0.387152949,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,LRP2,NA,hsa-mir-338,miRNA,-1,2.618172409,-0.395228413,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,LRP2,NA,hsa-mir-338,miRNA,-1,2.320989975,-0.380435107,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,LRP2,NA,hsa-mir-338,miRNA,-1,2.728349707,-0.368996416,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,LRP2,NA,hsa-mir-338,miRNA,-1,2.413381654,-0.383890337,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,LRP2,NA,hsa-mir-338,miRNA,-1,2.492321138,-0.392314546,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,LRP2,NA,hsa-mir-338,miRNA,-1,3.095385462,-0.386732147,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,LRP2,NA,hsa-mir-338,miRNA,-1,2.999172667,-0.37816203,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,LRP2,NA,hsa-mir-338,miRNA,-1,2.928325505,-0.355717712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,LRP2,NA,hsa-mir-338,miRNA,-1,2.178853063,-0.437853739,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,NF1,yes,FOXC1,TF,1,2.732738556,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,NF1,yes,MTF1,TF,1,2.585082296,0.325833084,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.032928344,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,NF1,yes,BACH1,TF,1,2.24461646,0.378324426,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.087227094,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,NF1,yes,MEF2A,TF,1,2.649342632,0.385471054,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,NF1,yes,CEBPB,TF,1,3.226007015,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,SEMA3C,NA,NR2E1,TF,-1,-2.257683643,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,SEMA3C,NA,NR3C1,TF,-1,-4.29063745,0.373622741,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.092597974,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,SEMA3C,NA,RORA,TF,-1,-3.697758686,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,TP53,yes,FOXC1,TF,-1,-4.854175065,0.437464091,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,TP53,yes,NR2E1,TF,-1,-5.14556202,0.597949929,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,TP53,yes,CEBPB,TF,-1,-4.989226568,0.403617678,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,TP53,yes,RORA,TF,-1,-6.248205922,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,TP53,yes,FOXC1,TF,-1,-6.191878823,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,ATRX,yes,SOX4,TF,1,4.320608964,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,ATRX,yes,E2F3,TF,1,4.884845517,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,IDH1,yes,SOX4,TF,1,8.802595253,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,IDH1,yes,E2F3,TF,1,9.941010032,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,NF1,yes,SOX4,TF,-1,-3.763917194,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,RB1,yes,SOX4,TF,-1,-2.810508688,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,TP53,yes,SOX4,TF,1,4.159930362,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,TP53,yes,E2F3,TF,1,3.862670451,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,ATRX,yes,TAL1,TF,-1,2.710301123,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,IDH1,yes,TAL1,TF,-1,3.694229497,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,TP53,yes,TAL1,TF,-1,3.769280586,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,SCN9A,NA,SP1,TF,-1,-2.560001494,0.317997393,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.058777177,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,SCN9A,NA,NFKB1,TF,-1,-2.431062202,0.849485157,yes,AntiCancerPhaseIV,MutationGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
ORPHENADRINE,Histamine H1 receptor antagonist,"HRH1,SCN3A,SCN5A,SCN9A","411,432,462,482,642,678,837,838,943,1178,1503,1729,1939,1940,2031,2033,2085,2106,2158,2519,3115,3153","5,30,42,48,77,81,91,126",0.6923076923076923,"462,482,642,678,837,838,1503,1729,1939,1940,2031,2033,2085,2106,2519,3153",NA,1,"5,30",NA,139.26656223653848,SCN9A,NA,SREBF2,TF,-1,-2.603859288,0.550231551,yes,AntiCancerPhaseIV,MutationGene,yes,0.02852884,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 8,O: 16 U: 0 A: 22,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,ATRX,yes,SOX11,TF,1,4.047321808,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,ATRX,yes,SOX5,TF,1,2.320613788,0.65153363,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,ATRX,yes,SOX11,TF,1,2.216145581,0.708130637,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,ATRX,yes,hsa-mir-146b,miRNA,-1,2.324127787,-0.407261545,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,ATRX,yes,hsa-mir-146b,miRNA,-1,2.213559684,-0.433408058,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,HYDIN,NA,SOX11,TF,-1,-3.288708933,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,IDH1,yes,SOX11,TF,1,7.547043549,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,IDH1,yes,SOX5,TF,1,4.326224967,0.65153363,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,IDH1,yes,SOX11,TF,1,4.359236272,0.708130637,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,NF1,yes,SOX11,TF,-1,-2.435305334,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,RB1,yes,SOX11,TF,-1,-3.088393837,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,RB1,yes,SOX5,TF,-1,-4.069467329,0.65153363,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,RB1,yes,SOX11,TF,-1,-4.529927082,0.708130637,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,TP53,yes,SOX11,TF,1,2.735834221,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,TP53,yes,SOX5,TF,1,2.013439285,0.65153363,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
PERAMPANEL,Glutamate receptor ionotropic AMPA antagonist,GRIA2,"329,1096,1100","73,133",0.5882352941176471,"329,1096",NA,NA,NA,NA,-151.4693588217647,TP53,yes,SOX11,TF,1,2.105071952,0.708130637,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 2 U: 0 A: 3,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,LEF1,TF,-1,-5.283671066,0.490108127,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,RORA,TF,-1,-5.726907249,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,FOXC1,TF,-1,-6.124032141,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,hsa-mir-504,miRNA,1,-5.765024776,-0.424987379,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,IDH1,yes,NFKB1,TF,-1,-7.644356643,0.438395898,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,IDH1,yes,LEF1,TF,-1,-7.304272808,0.490108127,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,IDH1,yes,RORA,TF,-1,-8.153350511,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,IDH1,yes,FOXC1,TF,-1,-7.881164458,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,LRP2,NA,hsa-mir-338,miRNA,-1,2.178853063,-0.437853739,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,SEMA3C,NA,RORA,TF,-1,-3.697758686,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,SEMA3C,NA,GATA2,TF,1,-3.909553681,-0.312140047,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016930102,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,TP53,yes,RORA,TF,-1,-6.248205922,0.368665976,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.02197661,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,TP53,yes,FOXC1,TF,-1,-6.191878823,0.337342603,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,TP53,yes,GATA2,TF,1,-6.517212167,-0.312140047,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016930102,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,ZNF281,TF,1,4.042022654,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,IDH1,yes,ZNF281,TF,1,8.864737973,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,TP53,yes,ZNF281,TF,1,3.722295568,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,SOX11,TF,1,4.047321808,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,SOX5,TF,1,2.320613788,0.65153363,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,SOX11,TF,1,2.216145581,0.708130637,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,hsa-mir-146b,miRNA,-1,2.324127787,-0.407261545,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,hsa-mir-146b,miRNA,-1,2.213559684,-0.433408058,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,HYDIN,NA,SOX11,TF,-1,-3.288708933,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,IDH1,yes,SOX11,TF,1,7.547043549,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,IDH1,yes,SOX5,TF,1,4.326224967,0.65153363,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,IDH1,yes,SOX11,TF,1,4.359236272,0.708130637,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,NF1,yes,SOX11,TF,-1,-2.435305334,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,RB1,yes,SOX11,TF,-1,-3.088393837,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,RB1,yes,SOX5,TF,-1,-4.069467329,0.65153363,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,RB1,yes,SOX11,TF,-1,-4.529927082,0.708130637,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,TP53,yes,SOX11,TF,1,2.735834221,0.623107666,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,TP53,yes,SOX5,TF,1,2.013439285,0.65153363,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.017516857,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,TP53,yes,SOX11,TF,1,2.105071952,0.708130637,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,SOX4,TF,1,4.320608964,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,E2F3,TF,1,4.884845517,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,IDH1,yes,SOX4,TF,1,8.802595253,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,IDH1,yes,E2F3,TF,1,9.941010032,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,NF1,yes,SOX4,TF,-1,-3.763917194,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,RB1,yes,SOX4,TF,-1,-2.810508688,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,TP53,yes,SOX4,TF,1,4.159930362,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,TP53,yes,E2F3,TF,1,3.862670451,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,ATRX,yes,TAL1,TF,-1,2.710301123,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,IDH1,yes,TAL1,TF,-1,3.694229497,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,TP53,yes,TAL1,TF,-1,3.769280586,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,SCN9A,NA,SP1,TF,-1,-2.560001494,0.317997393,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.058777177,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,SCN9A,NA,NFKB1,TF,-1,-2.431062202,0.849485157,yes,AntiCancerPhaseIV,MutationGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
TOPIRAMATE,Carbonic anhydrase II inhibitor,"CA2,GABRA3,GRIA2,SCN3A,SCN5A,SCN9A","329,405,411,432,943,1096,1100,1153,1178,1503,1638,1939,1977,2031,2106,2158","5,30,48,73,77,81,91,126,133",0.5,"329,405,1096,1503,1638,1939,1977,2031,2106",NA,1,"5,30",NA,-91.6597450934,SCN9A,NA,SREBF2,TF,-1,-2.603859288,0.550231551,yes,AntiCancerPhaseIV,MutationGene,yes,0.02852884,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 9,O: 9 U: 0 A: 16,None,TRUE
SAGOPILONE,Tubulin stabiliser,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,ATRX,yes,SATB1,TF,1,-4.65543183,-0.71963689,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
VERUBULIN,Tubulin disrupting agent,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,ATRX,yes,SATB1,TF,1,-4.65543183,-0.71963689,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
SAGOPILONE,Tubulin stabiliser,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,IDH1,yes,SATB1,TF,1,-5.900007864,-0.71963689,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
VERUBULIN,Tubulin disrupting agent,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,IDH1,yes,SATB1,TF,1,-5.900007864,-0.71963689,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
SAGOPILONE,Tubulin stabiliser,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,IDH1,yes,FOXO3,TF,1,-5.73882123,-0.490527263,yes,#N/A,RegulonGene,#N/A,0.030141898,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
VERUBULIN,Tubulin disrupting agent,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,IDH1,yes,FOXO3,TF,1,-5.73882123,-0.490527263,yes,#N/A,RegulonGene,#N/A,0.030141898,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
SAGOPILONE,Tubulin stabiliser,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,TP53,yes,SATB1,TF,1,-3.445753202,-0.71963689,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
VERUBULIN,Tubulin disrupting agent,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,TP53,yes,SATB1,TF,1,-3.445753202,-0.71963689,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
SAGOPILONE,Tubulin stabiliser,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,PTEN,yes,hsa-mir-296,miRNA,-1,2.192630142,-0.493720703,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
VERUBULIN,Tubulin disrupting agent,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,PTEN,yes,hsa-mir-296,miRNA,-1,2.192630142,-0.493720703,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
SAGOPILONE,Tubulin stabiliser,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,SCN9A,NA,SREBF2,TF,-1,-2.603859288,0.550231551,yes,#N/A,RegulonGene,yes,0.02852884,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
VERUBULIN,Tubulin disrupting agent,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,SCN9A,NA,SREBF2,TF,-1,-2.603859288,0.550231551,yes,#N/A,RegulonGene,yes,0.02852884,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
SAGOPILONE,Tubulin stabiliser,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,TCHH,NA,SREBF2,TF,-1,-3.736290305,0.550231551,yes,#N/A,RegulonGene,yes,0.02852884,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
VERUBULIN,Tubulin disrupting agent,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,TCHH,NA,SREBF2,TF,-1,-3.736290305,0.550231551,yes,#N/A,RegulonGene,yes,0.02852884,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
SAGOPILONE,Tubulin stabiliser,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,#N/A,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
VERUBULIN,Tubulin disrupting agent,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,#N/A,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
SAGOPILONE,Tubulin stabiliser,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,#N/A,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
VERUBULIN,Tubulin disrupting agent,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,#N/A,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
SAGOPILONE,Tubulin stabiliser,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,NF1,yes,SOX15,TF,-1,3.133037039,-0.560895341,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
VERUBULIN,Tubulin disrupting agent,"TUBA1C,TUBA4A,TUBB6","1178,1485,1563,2290,3545","24,126,152",0.4,"1563,2290",NA,1,24,NA,232.53418563,NF1,yes,SOX15,TF,-1,3.133037039,-0.560895341,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 2 U: 0 A: 5,Phase 2,FALSE
LEVOTHYROXINE,Thyroid hormone receptor agonist,THRA,"4,6,14","0,2,33",0.3333333333333333,4,NA,0.5,0,NA,440.85092853333333,ATRX,yes,THRA,TF,1,-4.557615519,-0.561605464,#N/A,AntiCancerPhaseIV,RegulatorGene,yes,0.083365205,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 1 U: 0 A: 3,None,TRUE
LEVOTHYROXINE,Thyroid hormone receptor agonist,THRA,"4,6,14","0,2,33",0.3333333333333333,4,NA,0.5,0,NA,440.85092853333333,ATRX,yes,THRA,TF,1,-4.598228236,-0.742742077,#N/A,AntiCancerPhaseIV,RegulatorGene,yes,0.083365205,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 1 U: 0 A: 3,None,TRUE
LEVOTHYROXINE,Thyroid hormone receptor agonist,THRA,"4,6,14","0,2,33",0.3333333333333333,4,NA,0.5,0,NA,440.85092853333333,ATRX,yes,THRA,TF,1,-2.592200444,-0.377760894,#N/A,AntiCancerPhaseIV,RegulatorGene,yes,0.083365205,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 1 U: 0 A: 3,None,TRUE
LEVOTHYROXINE,Thyroid hormone receptor agonist,THRA,"4,6,14","0,2,33",0.3333333333333333,4,NA,0.5,0,NA,440.85092853333333,IDH1,yes,THRA,TF,1,-7.183423488,-0.561605464,#N/A,AntiCancerPhaseIV,RegulatorGene,yes,0.083365205,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 1 U: 0 A: 3,None,TRUE
LEVOTHYROXINE,Thyroid hormone receptor agonist,THRA,"4,6,14","0,2,33",0.3333333333333333,4,NA,0.5,0,NA,440.85092853333333,IDH1,yes,THRA,TF,1,-6.20541669,-0.742742077,#N/A,AntiCancerPhaseIV,RegulatorGene,yes,0.083365205,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 1 U: 0 A: 3,None,TRUE
LEVOTHYROXINE,Thyroid hormone receptor agonist,THRA,"4,6,14","0,2,33",0.3333333333333333,4,NA,0.5,0,NA,440.85092853333333,IDH1,yes,THRA,TF,1,-2.384368228,-0.377760894,#N/A,AntiCancerPhaseIV,RegulatorGene,yes,0.083365205,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 3,O: 1 U: 0 A: 3,None,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.077155298,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,0.145774197,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.212169935,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.005689796,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.11761407,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
CETUXIMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.025269831,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Early Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.077155298,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.077155298,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,0.145774197,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,0.145774197,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.212169935,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.212169935,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.005689796,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.005689796,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.11761407,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.11761407,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
OSIMERTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.025269831,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
PANITUMUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.025269831,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.077155298,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.077155298,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,0.145774197,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,0.145774197,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.212169935,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.212169935,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.005689796,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.005689796,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.11761407,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.11761407,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
ERLOTINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.025269831,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
GEFITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.025269831,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 2,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.077155298,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,NA,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,0.145774197,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.212169935,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.005689796,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.11761407,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
NIMOTUZUMAB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.025269831,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 3,TRUE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,#N/A,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,#N/A,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,#N/A,MutationGene,yes,-0.077155298,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,#N/A,MutationGene,#N/A,-0.00778872,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,#N/A,MutationGene,#N/A,-0.00778872,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,#N/A,MutationGene,#N/A,-0.107024401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,#N/A,MutationGene,#N/A,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,#N/A,MutationGene,#N/A,-0.107024401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,#N/A,MutationGene,#N/A,0.145774197,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,#N/A,MutationGene,#N/A,-0.212169935,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,#N/A,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,#N/A,MutationGene,#N/A,0.005689796,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,#N/A,MutationGene,#N/A,0.102423629,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,#N/A,MutationGene,#N/A,0.102423629,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,#N/A,MutationGene,#N/A,-0.11761407,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,#N/A,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
EPITINIB,Epidermal growth factor receptor erbB1 inhibitor,EGFR,"943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,2523,2528,2597,2604,2823,2830,3675","45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.3,"1482,1558,1570,2528,2823,3675",NA,NA,NA,NA,-89.7917043505,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,#N/A,MutationGene,yes,-0.025269831,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 15,O: 6 U: 0 A: 20,Phase 1,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,#N/A,MutationGene,yes,0.009674745,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,#N/A,MutationGene,yes,0.009674745,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,#N/A,MutationGene,yes,-0.077155298,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,#N/A,MutationGene,#N/A,-0.00778872,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,#N/A,MutationGene,#N/A,-0.00778872,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,#N/A,MutationGene,#N/A,-0.107024401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,#N/A,MutationGene,#N/A,NA,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,#N/A,MutationGene,#N/A,-0.107024401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,#N/A,MutationGene,#N/A,0.145774197,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,#N/A,MutationGene,#N/A,-0.212169935,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,#N/A,MutationGene,yes,0.009674745,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,#N/A,MutationGene,#N/A,0.005689796,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,#N/A,MutationGene,#N/A,0.102423629,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,#N/A,MutationGene,#N/A,0.102423629,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,#N/A,MutationGene,#N/A,-0.11761407,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,#N/A,MutationGene,yes,0.009674745,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,#N/A,MutationGene,yes,-0.025269831,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,ATRX,yes,JUN,TF,-1,-5.881277643,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,GPR98,NA,JUN,TF,-1,-5.371566811,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,HMCN1,NA,JUN,TF,1,2.253516612,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,IDH1,yes,JUN,TF,-1,-12.06295946,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,NF1,yes,JUN,TF,1,4.427184185,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,SEMA3C,NA,JUN,TF,-1,-3.574024907,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,TP53,yes,JUN,TF,-1,-3.903924703,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,ATRX,yes,SOX4,TF,1,4.320608964,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,IDH1,yes,SOX4,TF,1,8.802595253,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,NF1,yes,SOX4,TF,-1,-3.763917194,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,RB1,yes,SOX4,TF,-1,-2.810508688,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,TP53,yes,SOX4,TF,1,4.159930362,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,ATRX,yes,ZNF281,TF,1,4.042022654,0.611008975,#N/A,#N/A,RegulonGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,#N/A,RegulonGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,IDH1,yes,ZNF281,TF,1,8.864737973,0.611008975,#N/A,#N/A,RegulonGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,TP53,yes,ZNF281,TF,1,3.722295568,0.611008975,#N/A,#N/A,RegulonGene,#N/A,-0.09934856,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,ATRX,yes,SMAD3,TF,-1,-6.889241371,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,ATRX,yes,SP4,TF,1,-6.892565053,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,IDH1,yes,SMAD3,TF,-1,-11.01853724,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,IDH1,yes,SP4,TF,1,-11.40938808,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,NF1,yes,SMAD3,TF,1,3.551596255,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,NF1,yes,SP4,TF,-1,3.578678744,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,SEMA3C,NA,SMAD3,TF,-1,-3.788104834,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,SEMA3C,NA,SP4,TF,1,-3.574070003,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,TP53,yes,SMAD3,TF,-1,-4.15408969,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,TP53,yes,SP4,TF,1,-4.657534739,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,ATRX,yes,SMAD1,TF,-1,-6.798971845,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,GPR98,NA,ZNF217,TF,-1,-3.842626506,0.785950115,yes,#N/A,RegulonGene,yes,-0.050900246,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,GPR98,NA,SMAD1,TF,-1,-3.370103078,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,IDH1,yes,SMAD1,TF,-1,-13.2131381,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,NF1,yes,ZNF217,TF,1,2.875243705,0.785950115,yes,#N/A,RegulonGene,yes,-0.050900246,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,SEMA3C,NA,SMAD1,TF,-1,-3.865292894,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
VANDETANIB,Epidermal growth factor receptor inhibitor,"EGFR,EPHA2,EPHB1,EPHB2,EPHB4,ERBB2,ERBB3","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2158,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.26666666666666666,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,7.106356575866666,TP53,yes,SMAD1,TF,-1,-5.045414645,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 26,Phase 3,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,#N/A,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,#N/A,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,#N/A,MutationGene,yes,-0.077155298,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,#N/A,MutationGene,#N/A,-0.00778872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,#N/A,MutationGene,#N/A,-0.00778872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,#N/A,MutationGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,#N/A,MutationGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,#N/A,MutationGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,#N/A,MutationGene,#N/A,0.145774197,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,#N/A,MutationGene,#N/A,-0.212169935,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,#N/A,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,#N/A,MutationGene,#N/A,0.005689796,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,#N/A,MutationGene,#N/A,0.102423629,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,#N/A,MutationGene,#N/A,0.102423629,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,#N/A,MutationGene,#N/A,-0.11761407,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,#N/A,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,#N/A,MutationGene,yes,-0.025269831,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,ATRX,yes,SMAD3,TF,-1,-6.889241371,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,ATRX,yes,JUN,TF,-1,-5.881277643,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,ATRX,yes,SP4,TF,1,-6.892565053,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,GPR98,NA,JUN,TF,-1,-5.371566811,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,HMCN1,NA,JUN,TF,1,2.253516612,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,IDH1,yes,SMAD3,TF,-1,-11.01853724,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,IDH1,yes,JUN,TF,-1,-12.06295946,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,IDH1,yes,SP4,TF,1,-11.40938808,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,NF1,yes,SMAD3,TF,1,3.551596255,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,NF1,yes,JUN,TF,1,4.427184185,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,NF1,yes,SP4,TF,-1,3.578678744,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,SEMA3C,NA,SMAD3,TF,-1,-3.788104834,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,SEMA3C,NA,JUN,TF,-1,-3.574024907,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,SEMA3C,NA,SP4,TF,1,-3.574070003,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,TP53,yes,SMAD3,TF,-1,-4.15408969,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,TP53,yes,JUN,TF,-1,-3.903924703,0.561847921,#N/A,#N/A,RegulonGene,#N/A,-0.209271379,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,TP53,yes,SP4,TF,1,-4.657534739,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,ATRX,yes,SMAD1,TF,-1,-6.798971845,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,GPR98,NA,ZNF217,TF,-1,-3.842626506,0.785950115,yes,#N/A,RegulonGene,yes,-0.050900246,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,GPR98,NA,SMAD1,TF,-1,-3.370103078,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,IDH1,yes,SMAD1,TF,-1,-13.2131381,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,NF1,yes,ZNF217,TF,1,2.875243705,0.785950115,yes,#N/A,RegulonGene,yes,-0.050900246,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,SEMA3C,NA,SMAD1,TF,-1,-3.865292894,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
TESEVATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,EPHB4,ERBB2","236,943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.24074074074074073,"236,1482,1558,1570,2528,2823,3675",NA,0,NA,NA,53.15617365907408,TP53,yes,SMAD1,TF,-1,-5.045414645,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 7 U: 0 A: 25,Phase 2,FALSE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,ATRX,yes,ARID5A,TF,-1,-3.119804505,0.558941883,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.080033004,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,ATRX,yes,FOXC1,TF,-1,-2.381727672,0.557897827,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.112566588,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,GPR98,NA,NFKB1,TF,-1,-4.207363504,0.716310266,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,IDH1,yes,NFKB1,TF,-1,-2.646123445,0.716310266,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,IDH1,yes,ARID5A,TF,-1,-2.93041491,0.558941883,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.080033004,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,MUC17,NA,NFKB1,TF,1,2.351765615,0.716310266,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,TP53,yes,ARID5A,TF,-1,-2.104594288,0.558941883,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.080033004,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,ATRX,yes,IRF1,TF,-1,-5.791696963,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,ATRX,yes,IRF3,TF,-1,-5.818280702,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,GPR98,NA,MAFB,TF,-1,-4.531877499,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,IDH1,yes,IRF1,TF,-1,-10.18006441,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,IDH1,yes,IRF3,TF,-1,-10.30114211,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,MUC17,NA,IRF1,TF,1,2.212941318,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,NF1,yes,MAFB,TF,1,3.661417824,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,TP53,yes,MAFB,TF,-1,-5.861605619,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,TP53,yes,IRF1,TF,-1,-6.073019022,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,TP53,yes,IRF3,TF,-1,-6.020568732,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
REGORAFENIB,Discoidin domain-containing receptor 2 inhibitor,"DDR2,FGFR1,RAF1","53,127,422,448,1889,2052,2837","33,64,174",0.2222222222222222,"127,1889",NA,NA,NA,NA,378.3158971444444,TP53,yes,MYBL1,TF,1,3.307806404,0.631273234,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.053208317,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 2 U: 0 A: 7,Phase 1,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,ATRX,yes,hsa-mir-20b,miRNA,1,-7.287713237,-0.377067606,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,GPR98,NA,ELF1,TF,-1,-3.243824198,0.408372024,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,SEMA3C,NA,ELF1,TF,-1,-4.31670568,0.408372024,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,TP53,yes,ELF1,TF,-1,-6.650590276,0.408372024,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,GPR98,NA,NFKB1,TF,-1,-2.689790982,0.361032258,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,IDH1,yes,NFKB1,TF,-1,-6.099677054,0.361032258,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,MUC17,NA,NFKB1,TF,1,2.358603796,0.361032258,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,NF1,yes,NFKB1,TF,1,4.46190652,0.361032258,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,ATRX,yes,THRA,TF,1,-2.592200444,-0.377760894,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.083365205,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,ATRX,yes,CTF1,TF,-1,-2.442122163,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,IDH1,yes,THRA,TF,1,-2.384368228,-0.377760894,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.083365205,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,IDH1,yes,NF1,TF,1,-2.353939544,-0.333435561,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.117624951,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,IDH1,yes,CTF1,TF,-1,-2.744662685,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,TP53,yes,ARID5A,TF,-1,-2.421952479,0.43852254,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.080033004,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,TP53,yes,NF1,TF,1,-2.338541186,-0.333435561,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.117624951,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,TP53,yes,CTF1,TF,-1,-2.80744841,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
CAFFEINE,Adenosine receptor antagonist,"ADORA1,ADORA2B,ADORA3","0,4,23,24,115,290,402,416,436,480,519,652,2388","2,16,91",0.16216216216216217,"4,519,2388",NA,0,NA,NA,337.1237977594595,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 13,None,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.077155298,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,0.145774197,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.212169935,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.005689796,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.11761407,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.025269831,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.077155298,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,0.145774197,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.212169935,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.005689796,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.11761407,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.025269831,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.077155298,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.00778872,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.107024401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,0.145774197,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,AntiCancerPhaseIV,MutationGene,#N/A,0.102423629,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.11761407,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,AntiCancerPhaseIV,MutationGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,AntiCancerPhaseIV,MutationGene,yes,0.009674745,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.025269831,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,#N/A,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.086584087,0.753422024,yes,#N/A,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,EMX2,TF,1,3.022872429,0.416164881,#N/A,#N/A,MutationGene,yes,-0.077155298,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,NR2E1,TF,1,1.974430777,0.678137178,#N/A,#N/A,MutationGene,#N/A,-0.00778872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,NR2E1,TF,1,-2.250201872,-0.46820395,#N/A,#N/A,MutationGene,#N/A,-0.00778872,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,IRF3,TF,1,3.522346586,0.7517377,#N/A,#N/A,MutationGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX15,TF,1,2.514898753,0.434594365,#N/A,#N/A,MutationGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,IRF3,TF,1,2.216935554,0.433478826,#N/A,#N/A,MutationGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF589,TF,-1,-2.240153136,0.363584081,#N/A,#N/A,MutationGene,#N/A,0.145774197,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,#N/A,MutationGene,#N/A,-0.212169935,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.178536735,0.328599874,yes,#N/A,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX11,TF,-1,-3.18870647,0.623107666,yes,#N/A,MutationGene,#N/A,0.005689796,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-2.161810436,0.392741256,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,RFX2,TF,1,2.175532782,0.706229399,yes,#N/A,MutationGene,#N/A,0.102423629,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,RFX2,TF,1,2.040466804,0.649985202,yes,#N/A,MutationGene,#N/A,0.102423629,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,LTF,TF,1,-2.243690693,-0.409178276,#N/A,#N/A,MutationGene,#N/A,-0.11761407,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,ZNF281,TF,-1,-1.982428779,0.706238859,#N/A,#N/A,MutationGene,#N/A,-0.09934856,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SATB1,TF,-1,-2.076037258,0.651796193,yes,#N/A,MutationGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,EGFR,yes,SOX9,TF,1,-2.995503365,-0.478372432,#N/A,#N/A,MutationGene,yes,-0.025269831,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SMAD3,TF,-1,-6.889241371,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SMAD1,TF,-1,-6.798971845,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SP4,TF,1,-6.892565053,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SMAD3,TF,-1,-6.889241371,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SMAD1,TF,-1,-6.798971845,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SP4,TF,1,-6.892565053,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SMAD3,TF,-1,-6.889241371,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SMAD1,TF,-1,-6.798971845,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SP4,TF,1,-6.892565053,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SMAD3,TF,-1,-6.889241371,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SMAD1,TF,-1,-6.798971845,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,ATRX,yes,SP4,TF,1,-6.892565053,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,GPR98,NA,ZNF217,TF,-1,-3.842626506,0.785950115,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.050900246,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,GPR98,NA,SMAD1,TF,-1,-3.370103078,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,GPR98,NA,ZNF217,TF,-1,-3.842626506,0.785950115,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.050900246,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,GPR98,NA,SMAD1,TF,-1,-3.370103078,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,GPR98,NA,ZNF217,TF,-1,-3.842626506,0.785950115,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.050900246,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,GPR98,NA,SMAD1,TF,-1,-3.370103078,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,GPR98,NA,ZNF217,TF,-1,-3.842626506,0.785950115,yes,#N/A,RegulonGene,yes,-0.050900246,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,GPR98,NA,SMAD1,TF,-1,-3.370103078,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SMAD3,TF,-1,-11.01853724,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SMAD1,TF,-1,-13.2131381,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SP4,TF,1,-11.40938808,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SMAD3,TF,-1,-11.01853724,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SMAD1,TF,-1,-13.2131381,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SP4,TF,1,-11.40938808,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SMAD3,TF,-1,-11.01853724,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SMAD1,TF,-1,-13.2131381,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SP4,TF,1,-11.40938808,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SMAD3,TF,-1,-11.01853724,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SMAD1,TF,-1,-13.2131381,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,IDH1,yes,SP4,TF,1,-11.40938808,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,ZNF217,TF,1,2.875243705,0.785950115,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.050900246,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,SMAD3,TF,1,3.551596255,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,SP4,TF,-1,3.578678744,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,ZNF217,TF,1,2.875243705,0.785950115,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.050900246,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,SMAD3,TF,1,3.551596255,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,SP4,TF,-1,3.578678744,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,ZNF217,TF,1,2.875243705,0.785950115,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.050900246,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,SMAD3,TF,1,3.551596255,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,SP4,TF,-1,3.578678744,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,ZNF217,TF,1,2.875243705,0.785950115,yes,#N/A,RegulonGene,yes,-0.050900246,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,SMAD3,TF,1,3.551596255,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,NF1,yes,SP4,TF,-1,3.578678744,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SMAD3,TF,-1,-3.788104834,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SMAD1,TF,-1,-3.865292894,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SP4,TF,1,-3.574070003,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SMAD3,TF,-1,-3.788104834,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SMAD1,TF,-1,-3.865292894,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SP4,TF,1,-3.574070003,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SMAD3,TF,-1,-3.788104834,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SMAD1,TF,-1,-3.865292894,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SP4,TF,1,-3.574070003,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SMAD3,TF,-1,-3.788104834,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SMAD1,TF,-1,-3.865292894,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,SEMA3C,NA,SP4,TF,1,-3.574070003,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SMAD3,TF,-1,-4.15408969,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SMAD1,TF,-1,-5.045414645,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
AFATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SP4,TF,1,-4.657534739,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 1,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SMAD3,TF,-1,-4.15408969,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SMAD1,TF,-1,-5.045414645,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
LAPATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SP4,TF,1,-4.657534739,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SMAD3,TF,-1,-4.15408969,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SMAD1,TF,-1,-5.045414645,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
DACOMITINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SP4,TF,1,-4.657534739,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,None,TRUE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SMAD3,TF,-1,-4.15408969,0.492466175,#N/A,#N/A,RegulonGene,#N/A,0.048050422,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SMAD1,TF,-1,-5.045414645,0.393197642,#N/A,#N/A,RegulonGene,yes,0.003597326,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
NERATINIB,Epidermal growth factor receptor erbB1 inhibitor,"EGFR,ERBB2","943,1100,1153,1163,1173,1398,1482,1519,1545,1558,1559,1560,1570,1574,1707,2523,2528,2597,2604,2823,2830,3008,3018,3675","17,45,48,54,60,66,72,77,78,80,89,93,103,133,153,168",0.16216216216216217,"1482,1558,1570,2528,2823,3675",NA,0,NA,NA,22.15979515783784,TP53,yes,SP4,TF,1,-4.657534739,-0.313601712,#N/A,#N/A,RegulonGene,#N/A,-0.047921097,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 16,O: 6 U: 0 A: 24,Phase 2,FALSE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,ATRX,yes,JUN,TF,-1,-5.881277643,0.561847921,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,GPR98,NA,JUN,TF,-1,-5.371566811,0.561847921,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,HMCN1,NA,JUN,TF,1,2.253516612,0.561847921,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,IDH1,yes,JUN,TF,-1,-12.06295946,0.561847921,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,JUN,TF,1,4.427184185,0.561847921,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,SEMA3C,NA,JUN,TF,-1,-3.574024907,0.561847921,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,JUN,TF,-1,-3.903924703,0.561847921,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,ATRX,yes,CTF1,TF,-1,-2.442122163,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,ATRX,yes,LMO2,TF,-1,-2.516396575,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,IDH1,yes,CTF1,TF,-1,-2.744662685,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,IDH1,yes,LMO2,TF,-1,-2.306972424,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,KLF4,TF,1,2.350563794,0.338006127,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177556715,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,LMO2,TF,1,2.227967106,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,ARID5A,TF,-1,-2.421952479,0.43852254,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.080033004,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,CTF1,TF,-1,-2.80744841,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,LMO2,TF,-1,-2.690461175,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,AHNAK2,NA,SOX2,TF,1,2.237746972,0.87384042,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,ATRX,yes,SOX2,TF,1,2.98927247,0.87384042,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,IDH1,yes,SOX2,TF,1,6.464929749,0.87384042,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,SOX2,TF,-1,-2.191217732,0.87384042,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,RB1,yes,SOX2,TF,-1,-2.758665827,0.87384042,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,RYR2,NA,SOX2,TF,1,2.832739257,0.87384042,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,ATRX,yes,THRA,TF,1,-2.592200444,-0.377760894,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.083365205,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,IDH1,yes,THRA,TF,1,-2.384368228,-0.377760894,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.083365205,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,IDH1,yes,NF1,TF,1,-2.353939544,-0.333435561,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.117624951,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
DASATINIB,Ephrin type-A receptor 2 inhibitor,"EPHA2,FGR,FYN,HCK,LCK,LYN","0,4,23,24,34,98,115,154,212,231,236,290,378,402,457,480,505,536,549,560,623,700,787","2,17,61",0.1282051282051282,"4,236,560",NA,0,NA,NA,304.64356735726494,TP53,yes,NF1,TF,1,-2.338541186,-0.333435561,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.117624951,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 3,O: 3 U: 0 A: 23,Phase 1,TRUE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,PIK3CA,yes,MAX,TF,1,2.58594412,0.856652566,yes,#N/A,MutationGene,#N/A,-0.177842791,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,PIK3CA,yes,MAX,TF,1,2.187067289,0.326974202,yes,#N/A,MutationGene,#N/A,-0.177842791,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,PIK3CA,yes,BCL6,TF,1,2.146642273,0.341602951,yes,#N/A,MutationGene,yes,-0.15023748,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,PIK3CA,yes,BCL6,TF,1,2.242427508,0.319923885,yes,#N/A,MutationGene,yes,-0.15023748,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,#N/A,RegulonGene,yes,0.04207445,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,#N/A,RegulonGene,#N/A,-0.082248802,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,AHNAK2,NA,REL,TF,-1,-2.147772694,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,#N/A,RegulonGene,#N/A,-0.116063008,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,ATRX,yes,TCF4,TF,1,-2.293281098,-0.314810655,yes,#N/A,RegulonGene,#N/A,0.041677824,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,ATRX,yes,REL,TF,-1,-2.480698048,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,#N/A,RegulonGene,yes,NA,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,#N/A,RegulonGene,#N/A,-0.032298401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,IDH1,yes,TCF4,TF,1,-2.270643248,-0.314810655,yes,#N/A,RegulonGene,#N/A,0.041677824,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,IDH1,yes,REL,TF,-1,-2.471894639,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,#N/A,RegulonGene,yes,0.100724844,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,MUC17,NA,REL,TF,1,2.913998413,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,#N/A,RegulonGene,yes,-0.057585056,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,#N/A,RegulonGene,#N/A,-0.116063008,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,#N/A,RegulonGene,#N/A,-0.032298401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,#N/A,RegulonGene,yes,0.04207445,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,NF1,yes,KLF4,TF,1,2.350563794,0.338006127,yes,#N/A,RegulonGene,#N/A,-0.177556715,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,#N/A,RegulonGene,yes,NA,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,NF1,yes,REL,TF,1,2.751122047,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,#N/A,RegulonGene,yes,-0.057585056,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,#N/A,RegulonGene,#N/A,-0.032298401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,TP53,yes,ARID5A,TF,-1,-2.421952479,0.43852254,#N/A,#N/A,RegulonGene,#N/A,0.080033004,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,TP53,yes,TCF4,TF,1,-2.498994021,-0.314810655,yes,#N/A,RegulonGene,#N/A,0.041677824,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,#N/A,RegulonGene,#N/A,-0.082248802,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,#N/A,RegulonGene,yes,0.100724844,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,TP53,yes,REL,TF,-1,-2.489513089,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,#N/A,RegulonGene,yes,-0.057585056,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
BUPARLISIB,PI3-kinase class I inhibitor,"PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526","1,2,3,36",0.075,"1307,1523,1526",NA,0.05128205128205128,3,NA,364.20191853,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,#N/A,RegulonGene,#N/A,-0.116063008,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 4,O: 3 U: 0 A: 17,Phase 3,FALSE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,ATRX,yes,THRA,TF,1,-2.592200444,-0.377760894,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.083365205,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,IDH1,yes,THRA,TF,1,-2.384368228,-0.377760894,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.083365205,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
IBRUTINIB,Tyrosine-protein kinase BTK inhibitor,BTK,"4,34,98,436,457,536,623,700,787",2,0.07407407407407407,4,NA,0,NA,NA,362.67390429259257,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 1 U: 0 A: 9,Phase 1,TRUE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,ATRX,yes,SOX4,TF,1,4.320608964,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,IDH1,yes,SOX4,TF,1,8.802595253,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,NF1,yes,SOX4,TF,-1,-3.763917194,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,RB1,yes,SOX4,TF,-1,-2.810508688,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,TP53,yes,SOX4,TF,1,4.159930362,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,PIK3CA,yes,MAX,TF,1,2.58594412,0.856652566,yes,#N/A,MutationGene,#N/A,-0.177842791,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,PIK3CA,yes,MAX,TF,1,2.187067289,0.326974202,yes,#N/A,MutationGene,#N/A,-0.177842791,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,PIK3CA,yes,BCL6,TF,1,2.146642273,0.341602951,yes,#N/A,MutationGene,yes,-0.15023748,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,PIK3CA,yes,BCL6,TF,1,2.242427508,0.319923885,yes,#N/A,MutationGene,yes,-0.15023748,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,#N/A,RegulonGene,yes,0.04207445,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,#N/A,RegulonGene,#N/A,-0.082248802,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,#N/A,RegulonGene,yes,0.043239717,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,AHNAK2,NA,REL,TF,-1,-2.147772694,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,#N/A,RegulonGene,#N/A,-0.116063008,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,ATRX,yes,TCF4,TF,1,-2.293281098,-0.314810655,yes,#N/A,RegulonGene,#N/A,0.041677824,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,ATRX,yes,REL,TF,-1,-2.480698048,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,#N/A,RegulonGene,yes,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,#N/A,RegulonGene,#N/A,-0.032298401,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,IDH1,yes,TCF4,TF,1,-2.270643248,-0.314810655,yes,#N/A,RegulonGene,#N/A,0.041677824,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,IDH1,yes,REL,TF,-1,-2.471894639,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,#N/A,RegulonGene,yes,0.043239717,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,#N/A,RegulonGene,yes,0.100724844,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,MUC17,NA,REL,TF,1,2.913998413,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,#N/A,RegulonGene,yes,-0.057585056,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,#N/A,RegulonGene,#N/A,-0.116063008,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,#N/A,RegulonGene,#N/A,-0.032298401,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,#N/A,RegulonGene,yes,0.04207445,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,#N/A,RegulonGene,yes,0.043239717,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,NF1,yes,KLF4,TF,1,2.350563794,0.338006127,yes,#N/A,RegulonGene,#N/A,-0.177556715,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,#N/A,RegulonGene,yes,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,NF1,yes,REL,TF,1,2.751122047,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,#N/A,RegulonGene,yes,-0.057585056,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,#N/A,RegulonGene,#N/A,-0.032298401,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,TP53,yes,ARID5A,TF,-1,-2.421952479,0.43852254,#N/A,#N/A,RegulonGene,#N/A,0.080033004,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,TP53,yes,TCF4,TF,1,-2.498994021,-0.314810655,yes,#N/A,RegulonGene,#N/A,0.041677824,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,#N/A,RegulonGene,#N/A,-0.082248802,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,#N/A,RegulonGene,yes,0.043239717,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,#N/A,RegulonGene,yes,0.100724844,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,TP53,yes,REL,TF,-1,-2.489513089,0.647551105,#N/A,#N/A,RegulonGene,#N/A,-0.016762885,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,#N/A,RegulonGene,yes,-0.057585056,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
FIMEPINOSTAT,Histone deacetylase inhibitor,"HDAC2,PIK3CA,PIK3CD","34,98,115,154,212,317,402,436,480,505,536,700,734,1307,1313,1523,1526,2158","1,2,3,36,77",0.06666666666666667,"1307,1523,1526",NA,0.05128205128205128,3,NA,301.38236076,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,#N/A,RegulonGene,#N/A,-0.116063008,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 5,O: 3 U: 0 A: 18,Early Phase 1,FALSE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,ATRX,yes,SOX4,TF,1,4.320608964,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,ATRX,yes,SOX4,TF,1,4.320608964,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,ATRX,yes,SOX4,TF,1,4.320608964,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,ATRX,yes,E2F3,TF,1,4.884845517,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,ATRX,yes,E2F3,TF,1,4.884845517,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,ATRX,yes,E2F3,TF,1,4.884845517,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,EGFR,yes,E2F3,TF,-1,-3.79990008,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,IDH1,yes,SOX4,TF,1,8.802595253,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,IDH1,yes,SOX4,TF,1,8.802595253,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,IDH1,yes,SOX4,TF,1,8.802595253,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,IDH1,yes,E2F3,TF,1,9.941010032,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,IDH1,yes,E2F3,TF,1,9.941010032,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,IDH1,yes,E2F3,TF,1,9.941010032,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,NF1,yes,SOX4,TF,-1,-3.763917194,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,NF1,yes,SOX4,TF,-1,-3.763917194,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,NF1,yes,SOX4,TF,-1,-3.763917194,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,RB1,yes,SOX4,TF,-1,-2.810508688,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,RB1,yes,SOX4,TF,-1,-2.810508688,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,RB1,yes,SOX4,TF,-1,-2.810508688,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,TP53,yes,SOX4,TF,1,4.159930362,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,TP53,yes,SOX4,TF,1,4.159930362,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,TP53,yes,SOX4,TF,1,4.159930362,0.808748524,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.085058244,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,TP53,yes,E2F3,TF,1,3.862670451,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,TP53,yes,E2F3,TF,1,3.862670451,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,TP53,yes,E2F3,TF,1,3.862670451,0.647913901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.212169935,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,ATRX,yes,TAL1,TF,-1,2.710301123,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,ATRX,yes,TAL1,TF,-1,2.710301123,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,ATRX,yes,TAL1,TF,-1,2.710301123,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,IDH1,yes,TAL1,TF,-1,3.694229497,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,IDH1,yes,TAL1,TF,-1,3.694229497,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,IDH1,yes,TAL1,TF,-1,3.694229497,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,TP53,yes,TAL1,TF,-1,3.769280586,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,TP53,yes,TAL1,TF,-1,3.769280586,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,TP53,yes,TAL1,TF,-1,3.769280586,-0.346417483,yes,AntiCancerPhaseIV,RegulonGene,yes,0.129286863,#N/A,TL-20-24CC77,TRUE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,SCN9A,NA,SP1,TF,-1,-2.560001494,0.317997393,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.058777177,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,SCN9A,NA,SP1,TF,-1,-2.560001494,0.317997393,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.058777177,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,SCN9A,NA,SP1,TF,-1,-2.560001494,0.317997393,#N/A,AntiCancerPhaseIV,MutationGene,yes,-0.058777177,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,SCN9A,NA,NFKB1,TF,-1,-2.431062202,0.849485157,yes,AntiCancerPhaseIV,MutationGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,SCN9A,NA,NFKB1,TF,-1,-2.431062202,0.849485157,yes,AntiCancerPhaseIV,MutationGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,SCN9A,NA,NFKB1,TF,-1,-2.431062202,0.849485157,yes,AntiCancerPhaseIV,MutationGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
LIDOCAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,SCN9A,NA,SREBF2,TF,-1,-2.603859288,0.550231551,yes,AntiCancerPhaseIV,MutationGene,yes,0.02852884,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
RILUZOLE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,SCN9A,NA,SREBF2,TF,-1,-2.603859288,0.550231551,yes,AntiCancerPhaseIV,MutationGene,yes,0.02852884,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
ROPIVACAINE,Sodium channel alpha subunit blocker,"SCN3A,SCN5A,SCN9A","411,432,943,1178,1503,2158","5,30,77,81,126",0.06666666666666667,1503,NA,1,"5,30",NA,-234.8021191,SCN9A,NA,SREBF2,TF,-1,-2.603859288,0.550231551,yes,AntiCancerPhaseIV,MutationGene,yes,0.02852884,#N/A,TL-20-24CC77,FALSE,FALSE,O: 2 U: 0 A: 5,O: 1 U: 0 A: 6,None,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,ATRX,yes,IRF1,TF,-1,-5.791696963,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,ATRX,yes,IRF3,TF,-1,-5.818280702,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,GPR98,NA,MAFB,TF,-1,-4.531877499,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,IDH1,yes,IRF1,TF,-1,-10.18006441,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,IDH1,yes,IRF3,TF,-1,-10.30114211,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,MUC17,NA,IRF1,TF,1,2.212941318,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,NF1,yes,MAFB,TF,1,3.661417824,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,TP53,yes,MAFB,TF,-1,-5.861605619,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,TP53,yes,IRF1,TF,-1,-6.073019022,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,TP53,yes,IRF3,TF,-1,-6.020568732,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,ATRX,yes,THRA,TF,1,-2.592200444,-0.377760894,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.083365205,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,ATRX,yes,LMO2,TF,-1,-2.516396575,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,IDH1,yes,THRA,TF,1,-2.384368228,-0.377760894,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.083365205,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,IDH1,yes,LMO2,TF,-1,-2.306972424,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,NF1,yes,LMO2,TF,1,2.227967106,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
PAZOPANIB,Macrophage colony stimulating factor receptor inhibitor,"FGFR1,LCK","4,53,154,231,290,378,448,457,480,505,536,549,787,2837","2,33",0.043478260869565216,4,NA,0,NA,NA,382.2037687065217,TP53,yes,LMO2,TF,-1,-2.690461175,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 1 U: 0 A: 14,Phase 2,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,AHNAK2,NA,MAFB,TF,-1,-2.189129275,0.8411072,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,ATRX,yes,SOX2,TF,1,-3.324662149,-0.553812371,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,ATRX,yes,THRA,TF,1,-2.592200444,-0.377760894,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.083365205,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,ATRX,yes,SOX11,TF,1,-2.634850089,-0.328058655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,IDH1,yes,SOX2,TF,1,-3.424753544,-0.553812371,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,IDH1,yes,THRA,TF,1,-2.384368228,-0.377760894,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.083365205,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,IDH1,yes,NF1,TF,1,-2.353939544,-0.333435561,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.117624951,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,IDH1,yes,SOX11,TF,1,-3.022124151,-0.328058655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,MUC17,NA,MAFB,TF,1,2.990821944,0.8411072,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,MUC17,NA,CEBPA,TF,1,2.820355873,0.456015837,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,SOX2,TF,-1,3.392877353,-0.553812371,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,MAFB,TF,1,3.629377207,0.8411072,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,KLF4,TF,1,2.350563794,0.338006127,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177556715,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,CEBPA,TF,1,3.105165775,0.456015837,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,SOX11,TF,-1,3.4034442,-0.328058655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,CEBPA,TF,-1,-1.982768616,0.456015837,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,NF1,TF,1,-2.338541186,-0.333435561,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.117624951,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,SOX11,TF,1,-2.39939708,-0.328058655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.005689796,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,ATRX,yes,NR1H2,TF,-1,-2.924803656,0.326990628,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.117235927,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,ATRX,yes,LMO2,TF,-1,-2.516396575,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,IDH1,yes,NR1H2,TF,-1,-2.815441518,0.326990628,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.117235927,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,IDH1,yes,LMO2,TF,-1,-2.306972424,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,NF1,yes,LMO2,TF,1,2.227967106,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,NR1H2,TF,-1,-2.643496844,0.326990628,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.117235927,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
VEDOLIZUMAB,Integrin alpha-4/beta-7 inhibitor,"ITGA4,ITGB7","0,4,24,34,98,154,212,231,290,293,436,445,457,480,505,549,555,623,652,662,700,1095","2,4",0.02564102564102564,4,NA,0.16666666666666666,4,NA,323.3719878294872,TP53,yes,LMO2,TF,-1,-2.690461175,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 1 U: 0 A: 22,None,TRUE
PENTOXIFYLLINE,Adenosine A2 receptor antagonist,"ADORA2B,PDE4A","416,1178","16,126",0,NA,NA,0,NA,NA,191.21463862857144,GPR98,NA,NFKB1,TF,-1,-2.689790982,0.361032258,yes,#N/A,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 2,Phase 1,FALSE
PENTOXIFYLLINE,Adenosine A2 receptor antagonist,"ADORA2B,PDE4A","416,1178","16,126",0,NA,NA,0,NA,NA,191.21463862857144,IDH1,yes,NFKB1,TF,-1,-6.099677054,0.361032258,yes,#N/A,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 2,Phase 1,FALSE
PENTOXIFYLLINE,Adenosine A2 receptor antagonist,"ADORA2B,PDE4A","416,1178","16,126",0,NA,NA,0,NA,NA,191.21463862857144,MUC17,NA,NFKB1,TF,1,2.358603796,0.361032258,yes,#N/A,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 2,Phase 1,FALSE
PENTOXIFYLLINE,Adenosine A2 receptor antagonist,"ADORA2B,PDE4A","416,1178","16,126",0,NA,NA,0,NA,NA,191.21463862857144,NF1,yes,NFKB1,TF,1,4.46190652,0.361032258,yes,#N/A,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 2,Phase 1,FALSE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,#N/A,RegulonGene,yes,-0.076876257,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,#N/A,RegulonGene,yes,0.04207445,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,#N/A,RegulonGene,#N/A,-0.082248802,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,#N/A,RegulonGene,yes,-0.068933334,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,#N/A,RegulonGene,#N/A,-0.116063008,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT6,TF,-1,-2.265956377,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT6,TF,-1,-2.265956377,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT6,TF,-1,-2.265956377,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT6,TF,-1,-2.265956377,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT6,TF,-1,-2.265956377,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,#N/A,RegulonGene,yes,-0.076876257,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,#N/A,RegulonGene,yes,-0.009695219,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,ATRX,yes,STAT6,TF,-1,-2.265956377,0.66222257,#N/A,#N/A,RegulonGene,yes,-0.01265308,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,#N/A,RegulonGene,yes,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,#N/A,RegulonGene,#N/A,-0.032298401,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT6,TF,-1,-2.232710956,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT6,TF,-1,-2.232710956,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT6,TF,-1,-2.232710956,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT6,TF,-1,-2.232710956,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT6,TF,-1,-2.232710956,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,#N/A,RegulonGene,yes,-0.076876257,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,#N/A,RegulonGene,yes,-0.009695219,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,IDH1,yes,STAT6,TF,-1,-2.232710956,0.66222257,#N/A,#N/A,RegulonGene,yes,-0.01265308,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,#N/A,RegulonGene,#N/A,0.069499965,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,#N/A,RegulonGene,yes,0.100724844,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,#N/A,RegulonGene,yes,-0.009695219,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,#N/A,RegulonGene,yes,-0.068933334,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,#N/A,RegulonGene,#N/A,-0.116063008,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,#N/A,RegulonGene,#N/A,-0.032298401,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT6,TF,1,2.53110771,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT6,TF,1,2.53110771,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT6,TF,1,2.53110771,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT6,TF,1,2.53110771,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT6,TF,1,2.53110771,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,#N/A,RegulonGene,yes,-0.076876257,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,#N/A,RegulonGene,yes,0.04207445,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,#N/A,RegulonGene,#N/A,0.069499965,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,#N/A,RegulonGene,yes,-0.009695219,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,#N/A,RegulonGene,yes,-0.068933334,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,#N/A,RegulonGene,yes,NA,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,#N/A,RegulonGene,#N/A,-0.032298401,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,NF1,yes,STAT6,TF,1,2.53110771,0.66222257,#N/A,#N/A,RegulonGene,yes,-0.01265308,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
DOBUTAMINE,Beta-2 adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPHEDRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
EPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
NOREPINEPHRINE,Adrenergic receptor agonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PROPRANOLOL,Beta-2 adrenergic receptor antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,#N/A,RegulonGene,#N/A,-0.082248802,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,#N/A,RegulonGene,#N/A,0.069499965,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,#N/A,RegulonGene,yes,0.100724844,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,#N/A,RegulonGene,yes,-0.009695219,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,#N/A,RegulonGene,yes,-0.068933334,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
CARVEDILOL,Adrenergic receptor beta antagonist,ADRB2,"34,59,98,154,290,378,402,457,480,536,549,700,787",2,0,NA,NA,0,NA,NA,358.76774873170734,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,#N/A,RegulonGene,#N/A,-0.116063008,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,Early Phase 1,FALSE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,ATRX,yes,STAT6,TF,-1,-2.265956377,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,IDH1,yes,NF1,TF,1,-2.353939544,-0.333435561,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.117624951,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,IDH1,yes,STAT6,TF,-1,-2.232710956,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,NF1,yes,STAT6,TF,1,2.53110771,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,TP53,yes,ARID5A,TF,-1,-2.421952479,0.43852254,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.080033004,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
GEMTUZUMAB,Myeloid cell surface antigen CD33 binding agent,CD33,"24,59,115,436,480,549,787",2,0,NA,NA,0,NA,NA,379.57116559473684,TP53,yes,NF1,TF,1,-2.338541186,-0.333435561,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.117624951,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,None,TRUE
ABATACEPT,T-lymphocyte activation antigen CD86 inhibitor,CD86,"652,734",2,0,NA,NA,0,NA,NA,348.9728896428571,ATRX,yes,TCF4,TF,1,-2.293281098,-0.314810655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.041677824,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
ABATACEPT,T-lymphocyte activation antigen CD86 inhibitor,CD86,"652,734",2,0,NA,NA,0,NA,NA,348.9728896428571,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
ABATACEPT,T-lymphocyte activation antigen CD86 inhibitor,CD86,"652,734",2,0,NA,NA,0,NA,NA,348.9728896428571,IDH1,yes,TCF4,TF,1,-2.270643248,-0.314810655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.041677824,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
ABATACEPT,T-lymphocyte activation antigen CD86 inhibitor,CD86,"652,734",2,0,NA,NA,0,NA,NA,348.9728896428571,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
ABATACEPT,T-lymphocyte activation antigen CD86 inhibitor,CD86,"652,734",2,0,NA,NA,0,NA,NA,348.9728896428571,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
ABATACEPT,T-lymphocyte activation antigen CD86 inhibitor,CD86,"652,734",2,0,NA,NA,0,NA,NA,348.9728896428571,TP53,yes,TCF4,TF,1,-2.498994021,-0.314810655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.041677824,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
ABATACEPT,T-lymphocyte activation antigen CD86 inhibitor,CD86,"652,734",2,0,NA,NA,0,NA,NA,348.9728896428571,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
ABEMACICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,ATRX,yes,SATB1,TF,1,3.039118543,0.650296832,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
PALBOCICLIB,Cyclin-dependent kinase 4/cyclin D1 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,ATRX,yes,SATB1,TF,1,3.039118543,0.650296832,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
RIBOCICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,ATRX,yes,SATB1,TF,1,3.039118543,0.650296832,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,FALSE
ABEMACICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,IDH1,yes,SATB1,TF,1,3.271856436,0.650296832,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
PALBOCICLIB,Cyclin-dependent kinase 4/cyclin D1 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,IDH1,yes,SATB1,TF,1,3.271856436,0.650296832,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
RIBOCICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,IDH1,yes,SATB1,TF,1,3.271856436,0.650296832,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,FALSE
ABEMACICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,NF1,yes,SATB1,TF,-1,-4.343950746,0.650296832,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
PALBOCICLIB,Cyclin-dependent kinase 4/cyclin D1 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,NF1,yes,SATB1,TF,-1,-4.343950746,0.650296832,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
RIBOCICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,NF1,yes,SATB1,TF,-1,-4.343950746,0.650296832,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,FALSE
ABEMACICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,TP53,yes,SATB1,TF,1,3.24921744,0.650296832,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
PALBOCICLIB,Cyclin-dependent kinase 4/cyclin D1 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,TP53,yes,SATB1,TF,1,3.24921744,0.650296832,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
RIBOCICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,TP53,yes,SATB1,TF,1,3.24921744,0.650296832,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,FALSE
ABEMACICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,ATRX,yes,SATB1,TF,1,-5.837271897,-0.366579749,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
PALBOCICLIB,Cyclin-dependent kinase 4/cyclin D1 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,ATRX,yes,SATB1,TF,1,-5.837271897,-0.366579749,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
ABEMACICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,ATRX,yes,LEF1,TF,-1,-6.284755928,0.413115929,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
PALBOCICLIB,Cyclin-dependent kinase 4/cyclin D1 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,ATRX,yes,LEF1,TF,-1,-6.284755928,0.413115929,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
RIBOCICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,ATRX,yes,SATB1,TF,1,-5.837271897,-0.366579749,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,FALSE
RIBOCICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,ATRX,yes,LEF1,TF,-1,-6.284755928,0.413115929,#N/A,#N/A,RegulonGene,yes,-0.147069167,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,FALSE
ABEMACICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
PALBOCICLIB,Cyclin-dependent kinase 4/cyclin D1 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
RIBOCICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,EGFR,yes,SATB1,TF,-1,2.205229764,-0.366579749,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,FALSE
ABEMACICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,IDH1,yes,SATB1,TF,1,-8.900132775,-0.366579749,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
PALBOCICLIB,Cyclin-dependent kinase 4/cyclin D1 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,IDH1,yes,SATB1,TF,1,-8.900132775,-0.366579749,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
ABEMACICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,IDH1,yes,LEF1,TF,-1,-8.229076699,0.413115929,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
PALBOCICLIB,Cyclin-dependent kinase 4/cyclin D1 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,IDH1,yes,LEF1,TF,-1,-8.229076699,0.413115929,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.147069167,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
RIBOCICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,IDH1,yes,SATB1,TF,1,-8.900132775,-0.366579749,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,FALSE
RIBOCICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,IDH1,yes,LEF1,TF,-1,-8.229076699,0.413115929,#N/A,#N/A,RegulonGene,yes,-0.147069167,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,FALSE
ABEMACICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,TP53,yes,SATB1,TF,1,-4.100022768,-0.366579749,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
PALBOCICLIB,Cyclin-dependent kinase 4/cyclin D1 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,TP53,yes,SATB1,TF,1,-4.100022768,-0.366579749,yes,AntiCancerPhaseIV,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,TRUE
RIBOCICLIB,Cyclin-dependent kinase 4 inhibitor,"CDK4,CDK6","1560,1569,1653","54,80",0,NA,NA,NA,NA,NA,235.21245792000002,TP53,yes,SATB1,TF,1,-4.100022768,-0.366579749,yes,#N/A,RegulonGene,yes,0.009674745,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 3,Phase 2,FALSE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,ATRX,yes,TCF4,TF,1,-2.293281098,-0.314810655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.041677824,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,ATRX,yes,SREBF1,TF,-1,-2.432672531,0.324370727,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.090115373,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,ATRX,yes,CTF1,TF,-1,-2.442122163,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,ATRX,yes,STAT6,TF,-1,-2.265956377,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,ATRX,yes,LMO2,TF,-1,-2.516396575,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,IDH1,yes,TCF4,TF,1,-2.270643248,-0.314810655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.041677824,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,IDH1,yes,SREBF1,TF,-1,-2.440443847,0.324370727,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.090115373,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,IDH1,yes,CTF1,TF,-1,-2.744662685,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,IDH1,yes,STAT6,TF,-1,-2.232710956,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,IDH1,yes,LMO2,TF,-1,-2.306972424,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,NF1,yes,STAT6,TF,1,2.53110771,0.66222257,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.01265308,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,NF1,yes,LMO2,TF,1,2.227967106,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,TP53,yes,TCF4,TF,1,-2.498994021,-0.314810655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.041677824,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,TP53,yes,SREBF1,TF,-1,-2.666923547,0.324370727,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.090115373,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,TP53,yes,CTF1,TF,-1,-2.80744841,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PEGFILGRASTIM,Granulocyte colony stimulating factor receptor agonist,CSF3R,"0,23,34,59,98,231,281,290,480,505,536,700,734",2,0,NA,NA,0,NA,NA,333.1017325820513,TP53,yes,LMO2,TF,-1,-2.690461175,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,ATRX,yes,SMAD3,TF,-1,-6.889241371,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,ATRX,yes,SMAD3,TF,-1,-6.889241371,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,ATRX,yes,SMAD1,TF,-1,-6.798971845,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,ATRX,yes,SMAD1,TF,-1,-6.798971845,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,ATRX,yes,SP4,TF,1,-6.892565053,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,ATRX,yes,SP4,TF,1,-6.892565053,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,GPR98,NA,ZNF217,TF,-1,-3.842626506,0.785950115,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.050900246,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,GPR98,NA,ZNF217,TF,-1,-3.842626506,0.785950115,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.050900246,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,GPR98,NA,SMAD1,TF,-1,-3.370103078,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,GPR98,NA,SMAD1,TF,-1,-3.370103078,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,IDH1,yes,SMAD3,TF,-1,-11.01853724,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,IDH1,yes,SMAD3,TF,-1,-11.01853724,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,IDH1,yes,SMAD1,TF,-1,-13.2131381,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,IDH1,yes,SMAD1,TF,-1,-13.2131381,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,IDH1,yes,SP4,TF,1,-11.40938808,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,IDH1,yes,SP4,TF,1,-11.40938808,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,NF1,yes,ZNF217,TF,1,2.875243705,0.785950115,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.050900246,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,NF1,yes,ZNF217,TF,1,2.875243705,0.785950115,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.050900246,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,NF1,yes,SMAD3,TF,1,3.551596255,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,NF1,yes,SMAD3,TF,1,3.551596255,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,NF1,yes,SP4,TF,-1,3.578678744,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,NF1,yes,SP4,TF,-1,3.578678744,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,SEMA3C,NA,SMAD3,TF,-1,-3.788104834,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,SEMA3C,NA,SMAD3,TF,-1,-3.788104834,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,SEMA3C,NA,SMAD1,TF,-1,-3.865292894,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,SEMA3C,NA,SMAD1,TF,-1,-3.865292894,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,SEMA3C,NA,SP4,TF,1,-3.574070003,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,SEMA3C,NA,SP4,TF,1,-3.574070003,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,TP53,yes,SMAD3,TF,-1,-4.15408969,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,TP53,yes,SMAD3,TF,-1,-4.15408969,0.492466175,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.048050422,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,TP53,yes,SMAD1,TF,-1,-5.045414645,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,TP53,yes,SMAD1,TF,-1,-5.045414645,0.393197642,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.003597326,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
PERTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,TP53,yes,SP4,TF,1,-4.657534739,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
TRASTUZUMAB,Receptor protein-tyrosine kinase erbB-2 inhibitor,ERBB2,"1574,1707,3008,3018",17,0,NA,NA,0,NA,NA,153.8674416382353,TP53,yes,SP4,TF,1,-4.657534739,-0.313601712,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.047921097,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 4,None,TRUE
Lenvatinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,ATRX,yes,IRF1,TF,-1,-5.791696963,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
Lenvatinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,ATRX,yes,IRF3,TF,-1,-5.818280702,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
Nilotinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,ATRX,yes,IRF1,TF,-1,-5.791696963,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,None,TRUE
Nilotinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,ATRX,yes,IRF3,TF,-1,-5.818280702,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,None,TRUE
INFIGRATINIB,Fibroblast growth factor receptor inhibitor,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,ATRX,yes,IRF1,TF,-1,-5.791696963,0.613434538,yes,#N/A,RegulonGene,yes,0.100724844,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Early Phase 1,FALSE
INFIGRATINIB,Fibroblast growth factor receptor inhibitor,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,ATRX,yes,IRF3,TF,-1,-5.818280702,0.510215172,#N/A,#N/A,RegulonGene,#N/A,-0.107024401,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Early Phase 1,FALSE
Lenvatinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,GPR98,NA,MAFB,TF,-1,-4.531877499,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
Nilotinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,GPR98,NA,MAFB,TF,-1,-4.531877499,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,None,TRUE
INFIGRATINIB,Fibroblast growth factor receptor inhibitor,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,GPR98,NA,MAFB,TF,-1,-4.531877499,0.400092703,#N/A,#N/A,RegulonGene,yes,0.043239717,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Early Phase 1,FALSE
Lenvatinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,IDH1,yes,IRF1,TF,-1,-10.18006441,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
Lenvatinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,IDH1,yes,IRF3,TF,-1,-10.30114211,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
Nilotinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,IDH1,yes,IRF1,TF,-1,-10.18006441,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,None,TRUE
Nilotinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,IDH1,yes,IRF3,TF,-1,-10.30114211,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,None,TRUE
INFIGRATINIB,Fibroblast growth factor receptor inhibitor,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,IDH1,yes,IRF1,TF,-1,-10.18006441,0.613434538,yes,#N/A,RegulonGene,yes,0.100724844,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Early Phase 1,FALSE
INFIGRATINIB,Fibroblast growth factor receptor inhibitor,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,IDH1,yes,IRF3,TF,-1,-10.30114211,0.510215172,#N/A,#N/A,RegulonGene,#N/A,-0.107024401,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Early Phase 1,FALSE
Lenvatinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,MUC17,NA,IRF1,TF,1,2.212941318,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
Nilotinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,MUC17,NA,IRF1,TF,1,2.212941318,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,None,TRUE
INFIGRATINIB,Fibroblast growth factor receptor inhibitor,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,MUC17,NA,IRF1,TF,1,2.212941318,0.613434538,yes,#N/A,RegulonGene,yes,0.100724844,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Early Phase 1,FALSE
Lenvatinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,NF1,yes,MAFB,TF,1,3.661417824,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
Nilotinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,NF1,yes,MAFB,TF,1,3.661417824,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,None,TRUE
INFIGRATINIB,Fibroblast growth factor receptor inhibitor,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,NF1,yes,MAFB,TF,1,3.661417824,0.400092703,#N/A,#N/A,RegulonGene,yes,0.043239717,Early Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Early Phase 1,FALSE
Lenvatinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,TP53,yes,MAFB,TF,-1,-5.861605619,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
Lenvatinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,TP53,yes,IRF1,TF,-1,-6.073019022,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
Lenvatinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,TP53,yes,IRF3,TF,-1,-6.020568732,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
Nilotinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,TP53,yes,MAFB,TF,-1,-5.861605619,0.400092703,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,None,TRUE
Nilotinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,TP53,yes,IRF1,TF,-1,-6.073019022,0.613434538,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,None,TRUE
Nilotinib,#N/A,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,TP53,yes,IRF3,TF,-1,-6.020568732,0.510215172,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.107024401,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,None,TRUE
INFIGRATINIB,Fibroblast growth factor receptor inhibitor,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,TP53,yes,MAFB,TF,-1,-5.861605619,0.400092703,#N/A,#N/A,RegulonGene,yes,0.043239717,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Early Phase 1,FALSE
INFIGRATINIB,Fibroblast growth factor receptor inhibitor,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,TP53,yes,IRF1,TF,-1,-6.073019022,0.613434538,yes,#N/A,RegulonGene,yes,0.100724844,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Early Phase 1,FALSE
INFIGRATINIB,Fibroblast growth factor receptor inhibitor,FGFR1,"53,448,2837",33,0,NA,NA,NA,NA,NA,464.58683758999996,TP53,yes,IRF3,TF,-1,-6.020568732,0.510215172,#N/A,#N/A,RegulonGene,#N/A,-0.107024401,Early Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 3,Early Phase 1,FALSE
DESFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,ATRX,yes,ZNF281,TF,1,4.042022654,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ESZOPICLONE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,ATRX,yes,ZNF281,TF,1,4.042022654,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ETOMIDATE,GABA-A receptor; anion channel positive modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,ATRX,yes,ZNF281,TF,1,4.042022654,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ISOFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,ATRX,yes,ZNF281,TF,1,4.042022654,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
MIDAZOLAM,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,ATRX,yes,ZNF281,TF,1,4.042022654,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
PROPOFOL,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,ATRX,yes,ZNF281,TF,1,4.042022654,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
SEVOFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,ATRX,yes,ZNF281,TF,1,4.042022654,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
DESFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ESZOPICLONE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ETOMIDATE,GABA-A receptor; anion channel positive modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ISOFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
MIDAZOLAM,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
PROPOFOL,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
SEVOFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,EGFR,yes,ZNF281,TF,-1,-4.213098501,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
DESFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,IDH1,yes,ZNF281,TF,1,8.864737973,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ESZOPICLONE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,IDH1,yes,ZNF281,TF,1,8.864737973,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ETOMIDATE,GABA-A receptor; anion channel positive modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,IDH1,yes,ZNF281,TF,1,8.864737973,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ISOFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,IDH1,yes,ZNF281,TF,1,8.864737973,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
MIDAZOLAM,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,IDH1,yes,ZNF281,TF,1,8.864737973,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
PROPOFOL,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,IDH1,yes,ZNF281,TF,1,8.864737973,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
SEVOFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,IDH1,yes,ZNF281,TF,1,8.864737973,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
DESFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,TP53,yes,ZNF281,TF,1,3.722295568,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ESZOPICLONE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,TP53,yes,ZNF281,TF,1,3.722295568,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ETOMIDATE,GABA-A receptor; anion channel positive modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,TP53,yes,ZNF281,TF,1,3.722295568,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ISOFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,TP53,yes,ZNF281,TF,1,3.722295568,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
MIDAZOLAM,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,TP53,yes,ZNF281,TF,1,3.722295568,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
PROPOFOL,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,TP53,yes,ZNF281,TF,1,3.722295568,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
SEVOFLURANE,GABA-A receptor; anion channel positive allosteric modulator,GABRA3,1153,77,0,NA,NA,NA,NA,NA,-404.1248038,TP53,yes,ZNF281,TF,1,3.722295568,0.611008975,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.09934856,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,NF1,yes,KLF4,TF,1,2.350563794,0.338006127,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177556715,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
ROMIDEPSIN,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,ATRX,yes,SOX4,TF,1,4.320608964,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 1,FALSE
BELINOSTAT,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,ATRX,yes,SOX4,TF,1,4.320608964,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
PANOBINOSTAT,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,ATRX,yes,SOX4,TF,1,4.320608964,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
VORINOSTAT,Histone deacetylase 2 inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,ATRX,yes,SOX4,TF,1,4.320608964,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
ROMIDEPSIN,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,IDH1,yes,SOX4,TF,1,8.802595253,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 1,FALSE
BELINOSTAT,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,IDH1,yes,SOX4,TF,1,8.802595253,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
PANOBINOSTAT,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,IDH1,yes,SOX4,TF,1,8.802595253,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
VORINOSTAT,Histone deacetylase 2 inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,IDH1,yes,SOX4,TF,1,8.802595253,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
ROMIDEPSIN,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,NF1,yes,SOX4,TF,-1,-3.763917194,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 1,FALSE
BELINOSTAT,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,NF1,yes,SOX4,TF,-1,-3.763917194,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
PANOBINOSTAT,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,NF1,yes,SOX4,TF,-1,-3.763917194,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
VORINOSTAT,Histone deacetylase 2 inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,NF1,yes,SOX4,TF,-1,-3.763917194,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
ROMIDEPSIN,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,RB1,yes,SOX4,TF,-1,-2.810508688,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 1,FALSE
BELINOSTAT,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,RB1,yes,SOX4,TF,-1,-2.810508688,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
PANOBINOSTAT,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,RB1,yes,SOX4,TF,-1,-2.810508688,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
VORINOSTAT,Histone deacetylase 2 inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,RB1,yes,SOX4,TF,-1,-2.810508688,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
ROMIDEPSIN,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,TP53,yes,SOX4,TF,1,4.159930362,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 1,FALSE
BELINOSTAT,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,TP53,yes,SOX4,TF,1,4.159930362,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
PANOBINOSTAT,Histone deacetylase inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,TP53,yes,SOX4,TF,1,4.159930362,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
VORINOSTAT,Histone deacetylase 2 inhibitor,HDAC2,2158,77,0,NA,NA,NA,NA,NA,-201.1741014,TP53,yes,SOX4,TF,1,4.159930362,0.808748524,#N/A,#N/A,RegulonGene,yes,-0.085058244,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
ALDESLEUKIN,Interleukin-2 receptor agonist,IL2RA,450,4,0,NA,NA,1,4,NA,326.5,MUC17,NA,MAFB,TF,1,2.703889482,0.867272751,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
BASILIXIMAB,Interleukin-2 receptor inhibitor,IL2RA,450,4,0,NA,NA,1,4,NA,326.5,MUC17,NA,MAFB,TF,1,2.703889482,0.867272751,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,Phase 2,FALSE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,ARID5A,TF,-1,-2.421952479,0.43852254,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.080033004,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,ARID5A,TF,-1,-2.421952479,0.43852254,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.080033004,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
SARILUMAB,Interleukin-6 receptor alpha subunit antagonist,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
TOCILIZUMAB,Interleukin-6 receptor alpha subunit inhibitor,IL6R,"34,98,115,402,457,505,536,549,623,652,700",2,0,NA,NA,0,NA,NA,347.66271941818184,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,None,TRUE
RIBAVIRIN,Inosine-5'-monophosphate dehydrogenase 1 inhibitor,IMPDH1,"245,1486",16,0,NA,NA,0,NA,NA,654.038364075,ATRX,yes,JUN,TF,-1,-4.139912642,0.395463171,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
THIOGUANINE,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,IMPDH1,"245,1486",16,0,NA,NA,0,NA,NA,654.038364075,ATRX,yes,JUN,TF,-1,-4.139912642,0.395463171,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
RIBAVIRIN,Inosine-5'-monophosphate dehydrogenase 1 inhibitor,IMPDH1,"245,1486",16,0,NA,NA,0,NA,NA,654.038364075,IDH1,yes,JUN,TF,-1,-5.997395483,0.395463171,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
THIOGUANINE,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,IMPDH1,"245,1486",16,0,NA,NA,0,NA,NA,654.038364075,IDH1,yes,JUN,TF,-1,-5.997395483,0.395463171,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
RIBAVIRIN,Inosine-5'-monophosphate dehydrogenase 1 inhibitor,IMPDH1,"245,1486",16,0,NA,NA,0,NA,NA,654.038364075,NF1,yes,JUN,TF,1,2.500531788,0.395463171,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
THIOGUANINE,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,IMPDH1,"245,1486",16,0,NA,NA,0,NA,NA,654.038364075,NF1,yes,JUN,TF,1,2.500531788,0.395463171,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.209271379,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
RIBAVIRIN,Inosine-5'-monophosphate dehydrogenase 1 inhibitor,IMPDH1,"245,1486",16,0,NA,NA,0,NA,NA,654.038364075,NF1,yes,SOX15,TF,-1,2.969062175,-0.47435886,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
THIOGUANINE,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,IMPDH1,"245,1486",16,0,NA,NA,0,NA,NA,654.038364075,NF1,yes,SOX15,TF,-1,2.969062175,-0.47435886,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,#N/A,RegulonGene,yes,0.04207445,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,#N/A,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,#N/A,RegulonGene,#N/A,0.021106578,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,IDH1,yes,NF1,TF,1,-2.353939544,-0.333435561,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.117624951,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,IDH1,yes,NF1,TF,1,-2.353939544,-0.333435561,#N/A,#N/A,RegulonGene,#N/A,0.117624951,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,#N/A,RegulonGene,#N/A,0.021106578,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,#N/A,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,#N/A,RegulonGene,yes,0.04207445,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,NF1,yes,KLF4,TF,1,2.350563794,0.338006127,yes,#N/A,RegulonGene,#N/A,-0.177556715,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,#N/A,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,#N/A,RegulonGene,#N/A,0.021106578,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,TP53,yes,NF1,TF,1,-2.338541186,-0.333435561,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.117624951,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BOSUTINIB,Tyrosine-protein kinase HCK inhibitor,"HCK,LYN","0,24,34,98,212,290,378,457,480,623,700",2,0,NA,NA,0,NA,NA,338.76519875142856,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 11,Phase 2,TRUE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,#N/A,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,#N/A,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,TP53,yes,NF1,TF,1,-2.338541186,-0.333435561,#N/A,#N/A,RegulonGene,#N/A,0.117624951,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
BAFETINIB,Tyrosine-protein kinase Lyn inhibitor,LYN,"0,24,98,212,290,457,480",2,0,NA,NA,0,NA,NA,322.9901808,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,#N/A,RegulonGene,#N/A,0.021106578,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 7,Phase 1,FALSE
CABOZANTINIB,Hepatocyte growth factor receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,ATRX,yes,SOX2,TF,1,-4.232443064,-0.638252698,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
CRIZOTINIB,ALK tyrosine kinase receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,ATRX,yes,SOX2,TF,1,-4.232443064,-0.638252698,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
CABOZANTINIB,Hepatocyte growth factor receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
CRIZOTINIB,ALK tyrosine kinase receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
ONARTUZUMAB,Hepatocyte growth factor receptor antagonist,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,ATRX,yes,SOX2,TF,1,-4.232443064,-0.638252698,#N/A,#N/A,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 1,FALSE
ONARTUZUMAB,Hepatocyte growth factor receptor antagonist,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,#N/A,RegulonGene,#N/A,0.104667031,Phase 1,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 1,FALSE
CABOZANTINIB,Hepatocyte growth factor receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,GPR98,NA,MAFB,TF,-1,-3.47135405,0.605209156,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
CRIZOTINIB,ALK tyrosine kinase receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,GPR98,NA,MAFB,TF,-1,-3.47135405,0.605209156,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
ONARTUZUMAB,Hepatocyte growth factor receptor antagonist,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,GPR98,NA,MAFB,TF,-1,-3.47135405,0.605209156,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 1,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 1,FALSE
CABOZANTINIB,Hepatocyte growth factor receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,IDH1,yes,SOX2,TF,1,-7.947673076,-0.638252698,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
CRIZOTINIB,ALK tyrosine kinase receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,IDH1,yes,SOX2,TF,1,-7.947673076,-0.638252698,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
CABOZANTINIB,Hepatocyte growth factor receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
CRIZOTINIB,ALK tyrosine kinase receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
ONARTUZUMAB,Hepatocyte growth factor receptor antagonist,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,IDH1,yes,SOX2,TF,1,-7.947673076,-0.638252698,#N/A,#N/A,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 1,FALSE
ONARTUZUMAB,Hepatocyte growth factor receptor antagonist,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,#N/A,RegulonGene,#N/A,0.104667031,Phase 1,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 1,FALSE
CABOZANTINIB,Hepatocyte growth factor receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,NF1,yes,SOX2,TF,-1,2.799177262,-0.638252698,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
CRIZOTINIB,ALK tyrosine kinase receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,NF1,yes,SOX2,TF,-1,2.799177262,-0.638252698,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
CABOZANTINIB,Hepatocyte growth factor receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,NF1,yes,MAFB,TF,1,3.116068486,0.605209156,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
CRIZOTINIB,ALK tyrosine kinase receptor inhibitor,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,NF1,yes,MAFB,TF,1,3.116068486,0.605209156,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 2,TRUE
ONARTUZUMAB,Hepatocyte growth factor receptor antagonist,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,NF1,yes,SOX2,TF,-1,2.799177262,-0.638252698,#N/A,#N/A,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 1,FALSE
ONARTUZUMAB,Hepatocyte growth factor receptor antagonist,MET,"447,557,3545",24,0,NA,NA,1,24,NA,101.70894705714286,NF1,yes,MAFB,TF,1,3.116068486,0.605209156,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 1,TL-20-24CC77,FALSE,TRUE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 3,Phase 1,FALSE
DOXYCYCLINE,Matrix metalloproteinase 7 inhibitor,MMP7,416,16,0,NA,NA,0,NA,NA,283.7193676,GPR98,NA,NFKB1,TF,-1,-2.689790982,0.361032258,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
DOXYCYCLINE,Matrix metalloproteinase 7 inhibitor,MMP7,416,16,0,NA,NA,0,NA,NA,283.7193676,IDH1,yes,NFKB1,TF,-1,-6.099677054,0.361032258,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
DOXYCYCLINE,Matrix metalloproteinase 7 inhibitor,MMP7,416,16,0,NA,NA,0,NA,NA,283.7193676,MUC17,NA,NFKB1,TF,1,2.358603796,0.361032258,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
DOXYCYCLINE,Matrix metalloproteinase 7 inhibitor,MMP7,416,16,0,NA,NA,0,NA,NA,283.7193676,NF1,yes,NFKB1,TF,1,4.46190652,0.361032258,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
ROFLUMILAST,Phosphodiesterase 4 inhibitor,PDE4A,1178,126,0,NA,NA,NA,NA,NA,67.875,PTEN,yes,hsa-mir-296,miRNA,-1,2.192630142,-0.493720703,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
PENTOXIFYLLINE,Adenosine A2 receptor antagonist,"ADORA2B,PDE4A","416,1178","16,126",0,NA,NA,0,NA,NA,191.21463862857144,PTEN,yes,hsa-mir-296,miRNA,-1,2.192630142,-0.493720703,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 2,Phase 1,FALSE
ROFLUMILAST,Phosphodiesterase 4 inhibitor,PDE4A,1178,126,0,NA,NA,NA,NA,NA,67.875,SCN9A,NA,SREBF2,TF,-1,-2.603859288,0.550231551,yes,AntiCancerPhaseIV,RegulonGene,yes,0.02852884,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
PENTOXIFYLLINE,Adenosine A2 receptor antagonist,"ADORA2B,PDE4A","416,1178","16,126",0,NA,NA,0,NA,NA,191.21463862857144,SCN9A,NA,SREBF2,TF,-1,-2.603859288,0.550231551,yes,#N/A,RegulonGene,yes,0.02852884,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 2,Phase 1,FALSE
ROFLUMILAST,Phosphodiesterase 4 inhibitor,PDE4A,1178,126,0,NA,NA,NA,NA,NA,67.875,TCHH,NA,SREBF2,TF,-1,-3.736290305,0.550231551,yes,AntiCancerPhaseIV,RegulonGene,yes,0.02852884,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 1,None,TRUE
PENTOXIFYLLINE,Adenosine A2 receptor antagonist,"ADORA2B,PDE4A","416,1178","16,126",0,NA,NA,0,NA,NA,191.21463862857144,TCHH,NA,SREBF2,TF,-1,-3.736290305,0.550231551,yes,#N/A,RegulonGene,yes,0.02852884,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 2,O: 0 U: 0 A: 2,Phase 1,FALSE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,AHNAK2,NA,REL,TF,-1,-2.147772694,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,ATRX,yes,TCF4,TF,1,-2.293281098,-0.314810655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.041677824,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,ATRX,yes,REL,TF,-1,-2.480698048,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,IDH1,yes,TCF4,TF,1,-2.270643248,-0.314810655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.041677824,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,IDH1,yes,REL,TF,-1,-2.471894639,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,MUC17,NA,REL,TF,1,2.913998413,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,NF1,yes,KLF4,TF,1,2.350563794,0.338006127,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.177556715,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,NF1,yes,REL,TF,1,2.751122047,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,TP53,yes,ARID5A,TF,-1,-2.421952479,0.43852254,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.080033004,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,TP53,yes,TCF4,TF,1,-2.498994021,-0.314810655,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.041677824,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,TP53,yes,REL,TF,-1,-2.489513089,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
IDELALISIB,PI3-kinase p110-delta subunit inhibitor,PIK3CD,"34,98,115,154,212,317,402,436,480,505,536,700,734",2,0,NA,NA,0,NA,NA,346.4587590722222,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 13,None,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,ATRX,yes,IRF1,TF,-1,-4.183187033,0.600050076,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,ATRX,yes,IRF1,TF,-1,-4.183187033,0.600050076,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,IDH1,yes,IRF1,TF,-1,-4.117200894,0.600050076,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,IDH1,yes,IRF1,TF,-1,-4.117200894,0.600050076,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,IRF1,TF,1,2.221658037,0.600050076,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,MUC17,NA,IRF1,TF,1,2.221658037,0.600050076,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
PIOGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,Phase 2,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
ROSIGLITAZONE,Peroxisome proliferator-activated receptor gamma agonist,PPARG,"34,35,290,436,457,480,652","2,18",0,NA,NA,0.13043478260869565,18,NA,346.3089329782609,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 7,None,TRUE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,AHNAK2,NA,IRF8,TF,-1,-2.732888044,0.66042547,yes,#N/A,RegulonGene,#N/A,-0.056906531,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,AHNAK2,NA,IRF2,TF,-1,-2.657713764,0.634500637,#N/A,#N/A,RegulonGene,#N/A,-0.082248802,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,AHNAK2,NA,MAFB,TF,-1,-2.666043323,0.546786061,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,ATRX,yes,IRF1,TF,-1,-2.912809687,0.77239752800000006,yes,#N/A,RegulonGene,yes,0.100724844,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,ATRX,yes,IRF3,TF,-1,-2.651689294,0.315564573,#N/A,#N/A,RegulonGene,#N/A,-0.107024401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,ATRX,yes,PRDM1,TF,-1,-2.673596678,0.369162541,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,ATRX,yes,hsa-mir-92,miRNA,1,-2.820748783,-0.305560112,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,IDH1,yes,IRF1,TF,-1,-3.449868682,0.77239752800000006,yes,#N/A,RegulonGene,yes,0.100724844,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,IDH1,yes,IRF3,TF,-1,-3.081034138,0.315564573,#N/A,#N/A,RegulonGene,#N/A,-0.107024401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,IDH1,yes,PRDM1,TF,-1,-2.80636077,0.369162541,#N/A,#N/A,RegulonGene,#N/A,-0.198188755,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,IDH1,yes,GTF2IRD1,TF,1,-2.561942929,-0.360459207,#N/A,#N/A,RegulonGene,#N/A,0.054824522,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,MUC17,NA,IRF1,TF,1,3.285335689,0.77239752800000006,yes,#N/A,RegulonGene,yes,0.100724844,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,MUC17,NA,IRF8,TF,1,3.396824646,0.66042547,yes,#N/A,RegulonGene,#N/A,-0.056906531,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,MUC17,NA,MAFB,TF,1,3.0877542,0.546786061,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,MUC2,NA,hsa-mir-92,miRNA,-1,2.17947807,-0.305560112,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,TP53,yes,IRF1,TF,-1,-3.543183602,0.77239752800000006,yes,#N/A,RegulonGene,yes,0.100724844,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,TP53,yes,IRF8,TF,-1,-3.297254306,0.66042547,yes,#N/A,RegulonGene,#N/A,-0.056906531,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,TP53,yes,IRF9,TF,-1,-3.485061106,0.510379518,#N/A,#N/A,RegulonGene,#N/A,-0.040414652,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,TP53,yes,IRF2,TF,-1,-3.523598766,0.634500637,#N/A,#N/A,RegulonGene,#N/A,-0.082248802,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,TP53,yes,IRF3,TF,-1,-3.544530676,0.315564573,#N/A,#N/A,RegulonGene,#N/A,-0.107024401,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,TP53,yes,MAFB,TF,-1,-3.635888423,0.546786061,#N/A,#N/A,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
MARIZOMIB,20S proteosome inhibitor,PSMB10,"40,75,102,444,625,703,2825,3303",87,0,NA,NA,NA,NA,NA,445.22640682727274,TP53,yes,GTF2IRD1,TF,1,-2.815045909,-0.360459207,#N/A,#N/A,RegulonGene,#N/A,0.054824522,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 8,Phase 3,FALSE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,SOX2,TF,1,-2.213351702,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF2,TF,-1,-2.224624352,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,SOX2,TF,1,-2.25647884,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,SOX2,TF,1,-2.205172173,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,SOX2,TF,-1,2.577714787,-0.35575208,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.076876257,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
SULFASALAZINE,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 1,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 1,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ASPIRIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
CELECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,Phase 2,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF2,TF,-1,-2.526007423,0.530384164,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.082248802,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ACETAMINOPHEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DEXKETOPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
DICLOFENAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ETORICOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
FLURBIPROFEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
INDOMETHACIN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
KETOROLAC,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
NAPROXEN,Cyclooxygenase inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
PARECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
ROFECOXIB,Cyclooxygenase-2 inhibitor,PTGS2,"34,98,290,378,402,457,480,505,536,549,623,652,700,787",2,0,NA,NA,0,NA,NA,353.89243045434785,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,#N/A,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 14,None,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,AHNAK2,NA,MAFB,TF,-1,-2.115779834,0.822776892,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,AHNAK2,NA,MEF2A,TF,-1,-2.222454042,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,AHNAK2,NA,MAFB,TF,-1,-2.115779834,0.822776892,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,ATRX,yes,HLX,TF,-1,-2.520929955,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,GPR98,NA,ATF5,TF,-1,-2.204320774,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,MAFB,TF,1,2.816125744,0.822776892,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,HLX,TF,1,2.993138216,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,MUC17,NA,MAFB,TF,1,2.816125744,0.822776892,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,MEF2A,TF,1,2.450562045,0.494010097,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.04207445,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,ATF5,TF,1,2.555485767,0.316741107,#N/A,AntiCancerPhaseIV,RegulonGene,yes,NA,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,NF1,yes,HLX,TF,1,2.736500385,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 3,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,ARID5A,TF,-1,-2.421952479,0.43852254,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.080033004,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
IMIQUIMOD,Toll-like receptor 7 agonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,MAFB,TF,-1,-2.555968391,0.822776892,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 2,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 2,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,ARID5A,TF,-1,-2.421952479,0.43852254,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.080033004,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,HLX,TF,-1,-2.610546847,0.560775682,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.017328457,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
HYDROXYCHLOROQUINE,Toll-like receptor 7 antagonist,TLR7,"34,115,290,378,402,436,440,457,480,536,652,787",2,0,NA,NA,0,NA,NA,367.5305200027027,TP53,yes,MAFB,TF,-1,-2.555968391,0.822776892,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,Phase 3,TL-20-24CC77,TRUE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 12,Phase 3,TRUE
CABAZITAXEL,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
DOCETAXEL,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
PACLITAXEL,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
VINBLASTINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
VINCRISTINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
COLCHICINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
ERIBULIN,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
VINORELBINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
IXABEPILONE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,ATRX,yes,PRRX2,TF,-1,-2.746730005,0.47873139,#N/A,#N/A,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,FALSE
CABAZITAXEL,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
DOCETAXEL,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
PACLITAXEL,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
VINBLASTINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
VINCRISTINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
COLCHICINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
ERIBULIN,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
VINORELBINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.104667031,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
IXABEPILONE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,IDH1,yes,PRRX2,TF,-1,-5.358649753,0.47873139,#N/A,#N/A,RegulonGene,#N/A,0.104667031,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,FALSE
CABAZITAXEL,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,NF1,yes,SOX15,TF,-1,3.133037039,-0.560895341,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
DOCETAXEL,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,NF1,yes,SOX15,TF,-1,3.133037039,-0.560895341,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
PACLITAXEL,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,NF1,yes,SOX15,TF,-1,3.133037039,-0.560895341,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
VINBLASTINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,NF1,yes,SOX15,TF,-1,3.133037039,-0.560895341,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
VINCRISTINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,NF1,yes,SOX15,TF,-1,3.133037039,-0.560895341,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,TRUE
COLCHICINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,NF1,yes,SOX15,TF,-1,3.133037039,-0.560895341,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
ERIBULIN,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,NF1,yes,SOX15,TF,-1,3.133037039,-0.560895341,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
VINORELBINE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,NF1,yes,SOX15,TF,-1,3.133037039,-0.560895341,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,NA,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,None,TRUE
IXABEPILONE,Tubulin inhibitor,TUBB6,"1485,3545",24,0,NA,NA,1,24,NA,214.84544696666666,NF1,yes,SOX15,TF,-1,3.133037039,-0.560895341,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 2,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 2,FALSE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAFB,TF,-1,-2.172241043,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,IRF8,TF,-1,-2.2800512,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPA,TF,-1,-2.172328804,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,REL,TF,-1,-2.147772694,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,REL,TF,-1,-2.147772694,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,REL,TF,-1,-2.147772694,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,REL,TF,-1,-2.147772694,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,REL,TF,-1,-2.147772694,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,REL,TF,-1,-2.147772694,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,CEBPB,TF,-1,-2.196328664,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,AHNAK2,NA,MAF,TF,-1,-2.191501875,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-2.175541046,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,STAT3,TF,-1,-2.566289742,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,REL,TF,-1,-2.480698048,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,REL,TF,-1,-2.480698048,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,REL,TF,-1,-2.480698048,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,REL,TF,-1,-2.480698048,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,REL,TF,-1,-2.480698048,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,REL,TF,-1,-2.480698048,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,CTF1,TF,-1,-2.442122163,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,CTF1,TF,-1,-2.442122163,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,CTF1,TF,-1,-2.442122163,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,CTF1,TF,-1,-2.442122163,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,CTF1,TF,-1,-2.442122163,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,CTF1,TF,-1,-2.442122163,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,NFIB,TF,1,-2.375391584,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-4.131174373,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-4.131174373,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-4.131174373,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-4.131174373,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-4.131174373,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,PRDM1,TF,-1,-4.131174373,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,LMO2,TF,-1,-2.516396575,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,LMO2,TF,-1,-2.516396575,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,LMO2,TF,-1,-2.516396575,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,LMO2,TF,-1,-2.516396575,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,LMO2,TF,-1,-2.516396575,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,ATRX,yes,LMO2,TF,-1,-2.516396575,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.195501565,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,NFKB1,TF,-1,-2.225406804,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.622549367,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.622549367,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.622549367,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.622549367,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.622549367,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,GPR98,NA,PRDM1,TF,-1,-2.622549367,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-2.248093013,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,STAT3,TF,-1,-2.63844727,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,REL,TF,-1,-2.471894639,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,REL,TF,-1,-2.471894639,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,REL,TF,-1,-2.471894639,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,REL,TF,-1,-2.471894639,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,REL,TF,-1,-2.471894639,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,REL,TF,-1,-2.471894639,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,CTF1,TF,-1,-2.744662685,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,CTF1,TF,-1,-2.744662685,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,CTF1,TF,-1,-2.744662685,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,CTF1,TF,-1,-2.744662685,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,CTF1,TF,-1,-2.744662685,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,CTF1,TF,-1,-2.744662685,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,NFIB,TF,1,-2.522357519,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-4.740408509,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-4.740408509,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-4.740408509,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-4.740408509,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-4.740408509,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,PRDM1,TF,-1,-4.740408509,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,LMO2,TF,-1,-2.306972424,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,LMO2,TF,-1,-2.306972424,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,LMO2,TF,-1,-2.306972424,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,LMO2,TF,-1,-2.306972424,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,LMO2,TF,-1,-2.306972424,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,IDH1,yes,LMO2,TF,-1,-2.306972424,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC16,NA,PRDM1,TF,-1,-2.217852394,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC16,NA,PRDM1,TF,-1,-2.217852394,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC16,NA,PRDM1,TF,-1,-2.217852394,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC16,NA,PRDM1,TF,-1,-2.217852394,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC16,NA,PRDM1,TF,-1,-2.217852394,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC16,NA,PRDM1,TF,-1,-2.217852394,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAFB,TF,1,2.943336999,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF8,TF,1,3.093016173,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT5A,TF,1,3.019814499,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,IRF1,TF,1,2.863266617,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,STAT3,TF,1,2.94398845,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPA,TF,1,2.947923378,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,REL,TF,1,2.913998413,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,REL,TF,1,2.913998413,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,REL,TF,1,2.913998413,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,REL,TF,1,2.913998413,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,REL,TF,1,2.913998413,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,REL,TF,1,2.913998413,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,CEBPB,TF,1,2.869876094,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,ELF1,TF,1,2.75840999,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,MAF,TF,1,3.015666237,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,MUC17,NA,NFKB1,TF,1,2.83206644,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,MAFB,TF,1,2.425771725,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.574187494,0.49130241,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,IRF8,TF,1,2.90631442,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT5A,TF,1,2.613402251,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,STAT3,TF,1,2.597585499,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPA,TF,1,2.4043706989999998,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,REL,TF,1,2.751122047,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,REL,TF,1,2.751122047,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,REL,TF,1,2.751122047,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,REL,TF,1,2.751122047,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,REL,TF,1,2.751122047,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,REL,TF,1,2.751122047,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,CEBPB,TF,1,2.430445551,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,ELF1,TF,1,2.268816852,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFKB1,TF,1,2.489584188,0.616066312,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.032298401,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,NFIB,TF,-1,2.492709698,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.695801819,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.695801819,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.695801819,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.695801819,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.695801819,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,PRDM1,TF,1,2.695801819,0.618108236,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.198188755,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,LMO2,TF,1,2.227967106,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,LMO2,TF,1,2.227967106,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,LMO2,TF,1,2.227967106,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,LMO2,TF,1,2.227967106,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,LMO2,TF,1,2.227967106,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,NF1,yes,LMO2,TF,1,2.227967106,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,FALSE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAFB,TF,-1,-2.5274087,0.812814349,#N/A,AntiCancerPhaseIV,RegulonGene,yes,0.043239717,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF8,TF,-1,-2.61507796,0.744643209,yes,AntiCancerPhaseIV,RegulonGene,#N/A,-0.056906531,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT5A,TF,-1,-2.684596666,0.631754842,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,0.069499965,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,IRF1,TF,-1,-2.494837325,0.60606359,yes,AntiCancerPhaseIV,RegulonGene,yes,0.100724844,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,STAT3,TF,-1,-2.774021,0.511500194,yes,AntiCancerPhaseIV,RegulonGene,yes,-0.009695219,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPA,TF,-1,-2.51682908,0.704293335,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.068933334,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,REL,TF,-1,-2.489513089,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,REL,TF,-1,-2.489513089,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,REL,TF,-1,-2.489513089,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,REL,TF,-1,-2.489513089,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,REL,TF,-1,-2.489513089,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,REL,TF,-1,-2.489513089,0.647551105,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.016762885,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CEBPB,TF,-1,-2.638430282,0.732438516,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.045695074,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,ELF1,TF,-1,-2.511669866,0.602234664,#N/A,AntiCancerPhaseIV,RegulonGene,yes,-0.057585056,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,MAF,TF,-1,-2.628142723,0.626308901,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.116063008,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CTF1,TF,-1,-2.80744841,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CTF1,TF,-1,-2.80744841,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CTF1,TF,-1,-2.80744841,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CTF1,TF,-1,-2.80744841,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CTF1,TF,-1,-2.80744841,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,CTF1,TF,-1,-2.80744841,0.309729292,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.335254042,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,NFIB,TF,1,-2.706090372,-0.346779171,yes,AntiCancerPhaseIV,RegulonGene,#N/A,0.021106578,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ALFACALCIDOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,LMO2,TF,-1,-2.690461175,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCIFEDIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,LMO2,TF,-1,-2.690461175,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CALCITRIOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,LMO2,TF,-1,-2.690461175,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
CHOLECALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,LMO2,TF,-1,-2.690461175,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ERGOCALCIFEROL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,LMO2,TF,-1,-2.690461175,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
PARICALCITOL,Vitamin D receptor agonist,VDR,"0,23,34,98,113,154,231,290,317,378,402,436,457,505,623,787","2,18",0,NA,NA,0.08196721311475409,18,NA,333.67402261147544,TP53,yes,LMO2,TF,-1,-2.690461175,0.31866658,#N/A,AntiCancerPhaseIV,RegulonGene,#N/A,-0.048143139,#N/A,TL-20-24CC77,TRUE,FALSE,O: 1 U: 0 A: 2,O: 0 U: 0 A: 16,None,TRUE
ADAVOSERTIB,Serine/threonine-protein kinase WEE1 inhibitor,WEE1,"424,1838",46,0,NA,NA,NA,NA,NA,245.07264072,ATRX,yes,SRF,TF,-1,-4.127898199,0.329871213,yes,#N/A,RegulonGene,#N/A,-0.008434734,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 1,FALSE
ADAVOSERTIB,Serine/threonine-protein kinase WEE1 inhibitor,WEE1,"424,1838",46,0,NA,NA,NA,NA,NA,245.07264072,IDH1,yes,SRF,TF,-1,-7.597149708,0.329871213,yes,#N/A,RegulonGene,#N/A,-0.008434734,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 1,FALSE
ADAVOSERTIB,Serine/threonine-protein kinase WEE1 inhibitor,WEE1,"424,1838",46,0,NA,NA,NA,NA,NA,245.07264072,IDH1,yes,NFKB1,TF,-1,-8.864262572,0.612774245,yes,#N/A,RegulonGene,#N/A,-0.032298401,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 1,FALSE
ADAVOSERTIB,Serine/threonine-protein kinase WEE1 inhibitor,WEE1,"424,1838",46,0,NA,NA,NA,NA,NA,245.07264072,LRP2,NA,hsa-mir-138,miRNA,-1,4.396183239,-0.363984026,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 1,FALSE
ADAVOSERTIB,Serine/threonine-protein kinase WEE1 inhibitor,WEE1,"424,1838",46,0,NA,NA,NA,NA,NA,245.07264072,MUC17,NA,hsa-mir-138,miRNA,1,-2.128767736,-0.363984026,#N/A,#N/A,RegulonGene,#N/A,NA,Phase 1,TL-20-24CC77,FALSE,FALSE,O: 0 U: 0 A: 1,O: 0 U: 0 A: 2,Phase 1,FALSE
